Search the web
Sign In
New User? Sign Up
medicalerrors-solutions · medical errors & solutions, support
? Already a member? Sign in to Yahoo!

Yahoo! Groups Tips

Did you know...
Show off your group to the world. Share a photo of your group with us.

Best of Y! Groups

   Check them out and nominate your group.
Having problems with message search? Fill out this form to ensure your group is one of the first to be migrated to the new message search system.

Messages

  Messages Help
Advanced
Messages 1059 - 1090 of 1119   Newest  |  < Newer  |  Older >  |  Oldest
Messages: Show Message Summaries   (Group by Topic) Sort by Date v  
#1090 From: pulsecolo <pulsecolo@...>
Date: Sat Nov 18, 2006 7:24 am
Subject: What Kills 5 Times As Many Americans As AIDS? Hosp Infections
pulsecolo
Offline Offline
Send Email Send Email
 



 
November 14, 2006
Op-Ed Contributor
To Catch a Deadly Germ
WHAT kills more than five times as many Americans as AIDS? Hospital infections, which account for an estimated 100,000 deaths every year.
Yet the Centers for Disease Control and Prevention, which are calling for voluntary blood testing of all patients to stem the spread of AIDS, have chosen not to recommend a test that is essential to stop the spread of another killer sweeping through our nation’s hospitals: M.R.S.A., or methicillin-resistant Staphylococcus aureus. The C.D.C. guidelines to prevent hospital infections, released last month, conspicuously omit universal testing of patients for M.R.S.A.
That’s unfortunate. Research shows that the only way to prevent M.R.S.A. infections is to identify which patients bring the bacteria into the hospital. The M.R.S.A. test costs no more than the H.I.V. test and is less invasive, a simple nasal or skin swab.
Staph bacteria are the most prevalent infection-causing germs in most hospitals, and increasingly these infections cannot be cured with ordinary antibiotics. Sixty percent of staph infections are now drug resistant (that is, M.R.S.A.), up from 2 percent in 1974.
Some people carry M.R.S.A. germs in their noses or on their skin without realizing it. The bacteria do not cause infection unless they get inside the body — usually via a catheter, a ventilator, or an incision or other open wound. Once admitted to a hospital, these patients shed the germs on bedrails, wheelchairs, stethoscopes and other surfaces, where M.R.S.A. can live for many hours.
Doctors and other caregivers who lean over an M.R.S.A.-positive patient often pick up the germ on their hands, gloves or lab coats and carry it along to their next patient.
The blood-pressure cuffs that nurses wrap around patients’ bare arms frequently carry live bacteria, including M.R.S.A. In a recent study at a French teaching hospital, 77 percent of blood-pressure cuffs wheeled from room to room were contaminated. Another study linked contaminated blood-pressure cuffs to several infected infants in the nursery at the University of Iowa hospital.
Among developed nations, the United States has one of the worst records of curbing drug-resistant infections, according to the Sentry Antimicrobial Surveillance Program, an international effort to monitor drug-resistant germs. In this country, M.R.S.A. hospital infections increased 32-fold from 1976 to 2003, according to the C.D.C.
In the 1980s, Denmark, Finland and the Netherlands faced similarly soaring rates of M.R.S.A., but nearly eradicated it. How? By screening patients and requiring health care workers treating patients with M.R.S.A. to wear gowns and gloves and use dedicated equipment to prevent the spread. The Dutch called their strategy “search and destroy.”
A growing number of hospitals in the United States have proved that such precautions work here, too. Recently, a pilot program using screening at Presbyterian University Hospital, in Pittsburgh, reduced M.R.S.A. infections by 90 percent. At a Yale-affiliated hospital in New Haven, screening reduced M.R.S.A. infections in intensive care by two-thirds.
And a recently completed nine-year study at the Brigham and Women’s Hospital, in Boston, found that screening led to a 75 percent drop in M.R.S.A. bloodstream infections among intensive-care patients and a 67 percent decline throughout the hospital. Earlier efforts to stop these infections by installing many more dispensers of hand cleanser and conducting a yearlong educational campaign on hand hygiene had no effect.
Some public health advocates recommend screening only “high-risk” patients — those who recently have been hospitalized, live in nursing homes or have kidney disease. Partial screening is somewhat effective, but universal screening prevents the most infections.
Can hospitals afford to screen for M.R.S.A.? They cannot afford not to. Infections wipe out hospital profits. When a patient develops an infection and has to spend many additional weeks hospitalized, Medicare does not pay for most of that additional care.
Treating hospital infections costs an estimated $30.5 billion a year in the United States. Prevention, on the other hand, is inexpensive and requires no capital outlays. A pilot program at the University of Pittsburgh found that screening tests, gowns and other precautions cost only $35,000 a year, and saved more than $800,000 a year in infection costs. A review of similar cost analyses, published in The Lancet in September, concluded that M.R.S.A. screening increases hospital profits — as it saves lives.
Yet, for a decade, the C.D.C. has rebuffed calls for screening, most recently from a committee of the Society for Healthcare Epidemiologists of America. C.D.C. officials claim that more research is needed to prove the benefits of screening. More research cannot hurt, but we know enough already to move ahead.
Some hospitals are leading the way, including Evanston Northwestern, in Illinois; the Veterans Affairs medical centers; New England Baptist Hospital, in Boston; and Johns Hopkins Hospital, in Baltimore.
The C.D.C.’s lax guidelines give many other hospitals an excuse to do too little. Every year of delay costs thousands of lives and billions of dollars.
Betsy McCaughey, a former lieutenant governor of New York, is the founder of the Committee to Reduce Infection Deaths.



Sponsored Link

$420,000 Mortgage for $1,399/month - Think You Pay Too Much For Your Mortgage? Find Out!

#1089 From: pulsecolo <pulsecolo@...>
Date: Sat Oct 14, 2006 1:37 pm
Subject: COMPETITION ANNOUNCEMENT: Design a Nano-Hazard Symbol
pulsecolo
Offline Offline
Send Email Send Email
 
COMPETITION ANNOUNCEMENT: Design a Nano-Hazard Symbol
ETC Group announces International Graphic Design Competition
CALL FOR ENTRIES

Biotechnology, nuclear power, toxic chemicals, electromagnetic 
radiation -- each of these technological hazards has a universally 
recognized warning symbol associated with it. So why not 
nanotechnology -- the world's most powerful (and potentially 
dangerous) technology?

Concerned citizens everywhere are invited to submit their designs for 
a universal Nanotechnology Hazard Symbol at:  http://www.etcgroup.org/
nanohazard

Entries will be judged by a panel of eminent judges convened by the 
ETC Group (Action Group on Erosion Technology and Concentration, 
www.etcgroup.org). These judges include Dr. Vyvyan Howard (Editor of 
the Journal of Nanotoxicity), Dr. Gregor Wolbring (The Canadian 
Advisory Commitee on Nanotech Standardisation), Chee Yoke Ling (Third 
World Network), Claire Pentecost (Associate Professor and Chair of 
the Photography Department at the School of the Art Institute of 
Chicago), Rory O'Neill (Editor of Hazards magazine) and Dr. Alexis 
Vlandas (Nanotechnology Spokesperson for International Network of 
Engineers and Scientists for Global Responsibility). Entries will 
also be judged by participants at the World Social Forum, Nairobi, 
Kenya, 20-25 January 2007.

The winning entry will be submitted to international standard-setting 
bodies responsible for hazard characterisation, to international 
governmental organisations and to national governments as a proposed 
symbol for nanotechnology hazards.

Closing date: 8 January 2007

A gallery of entries submitted will be available at http://
www.etcgroup.org/gallery2/v/nanohazard/

Why Do We Need a Nano-Hazard Symbol?

Nanotechnology, the manipulation of matter at the tiny level of atoms 
and molecules, has created a new class of materials with unusual 
properties and new toxicities.

It used to be that nanotechnology was the stuff of science fiction. 
Today, however, there are over one thousand nanotechnology companies 
worldwide. Nanoparticles, nanotubes and other engineered 
nanomaterials are already in use in hundreds of everyday consumer 
products, raising significant health, safety and environmental 
concerns. Nanoparticles are able to move around the body and the 
environment more readily than larger particles of pollution. Because 
of their extremely small size and large surface area nanoparticles 
may be more reactive and more toxic than larger particles of the same 
substance. They have been compared to asbestos by leading insurance 
companies who worry their health impact could lead to massive claims. 
At least one US-based insurance company has canceled coverage of 
small companies involved with nanotechnology. Unlike more familiar 
forms of pollution arising from new technologies, nano-hazards 
(potentially endangering consumers, workers and the environment) have 
yet to be fully characterized, regulated or even subject to safety 
testing. The US Food and Drug Administration will have its first 
public meeting about regulating nanomaterials on October 10, 2006. 
Most governments worldwide have yet to even begin thinking about nano-
regulation. Nonetheless, nanoparticles invisible to the naked eye are 
already in foods, cosmetics, pesticides and clothing without even 
being labelled. Every day laboratory and factory workers could be 
inhaling and ingesting nanoparticles while the rest of us may be 
unwittingly putting them on our skin, in our body or in the
environment.

It's not just a safety question. Nanotechnology also raises new 
societal hazards: The granting of patents on nano-scale materials and 
processes, and even elements of the periodic table, allows for 
increased corporate power and monopoly over the smallest parts of 
nature. Some designer nanomaterials may come to replace natural 
products such as cotton, rubber and metals -- displacing the 
livelihoods of some of the poorest and most vulnerable people in the 
world.  In the near future the merger of nanotechnology with 
biotechnology (in nano-biotechnology applications such as synthetic 
biology) will lead to new designer organisms, modified at the 
molecular level, posing new biosafety threats. Nano-enabled 
technologies also aim to 'enhance' human beings and 'fix' the 
disabled, a goal that raises troubling ethical issues and the specter 
of a new divide between the technologically "improved" and
"unimproved."

ETC Group has called for a moratorium on nanoparticle production and 
release to allow for a full societal debate and until such time as 
precautionary regulations are in place to protect workers, consumers 
and the environment. Standard setting bodies around the world are now 
scrambling to agree on nomenclature that can describe nanoparticles 
and nanomaterials. A common, internationally-recognized symbol 
warning of the presence of engineered nanomaterials is equally overdue.

For a short and simple introduction to Nanotechnology see "A Tiny 
Primer on Nano-scale Technologies," available online:  http://
www.etcgroup.org/en/materials/publications.html?id=55


Details Of The Competition:

We are asking concerned people everywhere (including artists, 
designers, scientists, students, regulators and members of the 
public) to submit possible designs for an international Nano-Hazard 
warning symbol that could be used to identify the presence of 
nanmoaterials. This symbol could, for example, be placed on products 
containing nanomaterials, in laboratories or factories where workers 
handle nanoparticles, or on containers transporting nanomaterials. 
The symbol should be simple,  easy to recognize and communicate 
clearly the new, potential hazards that result when matter is 
manipulated at the nanoscale (1 billionth of a metre -- the size of 
atoms and molecules).

We encourage participants to be as creative as possible in inventing 
a new nano-hazard symbol. Images can be designed on computer or by 
hand, scanned, photographed or otherwise rendered in 2 dimensions -- 
either using colour or in black and white. Entries will be judged on 
their conceptual as well as artistic merit. Descriptions and 
explanations accompanying the entries will be very welcome.

For examples of existing hazard warning symbols for comparison see 
http://en.wikipedia.org/wiki/Hazard_symbol

Participants can submit as many different entries as they wish. Each 
entry should be submitted seperately. Entries can be submitted in one 
of 3 ways:
1) Upload electronically using the upload form at http://
www.etcgroup.org/nanohazard
2) Email as a jpeg or gif file to nanohazard@...
3) Send by post to Nano-Hazard Competition, ETC Group, 431 Gilmour 
Street, Ottawa, Ontario, K2P 0R5. Canada

Please include your name, country and a contact email or postal
address.

All submitted entries will be treated as non-copyright and in the 
public domain unless the submitter wishes to place them under a 
creative commons license allowing free non-commercial use (see 
details here http://www.creativecommons.org). Entries submitted with 
copyright conditions (other than creative commons) will not be 
considered. Entries sent by post will not be returned.

The closing date for entries is 8th January 2007.

Judging will be in two parts:

Judging Panel: A selection of entries will first be made by a panel 
of eminent judges chosen by the ETC Group.
This panel includes:
Dr. Vyvyan Howard, Founding editor of the Journal of Nanotoxicology.
Dr. Gregor Wolbring, The Canadian Advisory Commitee on Nanotech 
Standardisation.
Chee Yoke Ling, Legal Advisor, Third World Network.
Claire Pentecost, Artist, Writer, Associate Professor and Chair of 
the Photography Department at the School of the Art Institute of
Chicago
Rory O Neill, Editor of Hazards (trade union workplace safety
magazine).
Dr. Alexis Vlandas, Nanotechnology spokesperson for International 
Network of Engineers and Scientists for Global Responsibility.

Public Judging: The selected entries will then be displayed at the 
World Social Forum in Nairobi, Kenya (20- 25 January 2007) for civil 
society attendees to judge. We also encourage everyone to view the 
gallery of submitted artwork online and submit comments there.


More Information:

For a short introduction to nanotechnology see:  "A Tiny Primer on 
Nano-scale Technologies" available online:  http://www.etcgroup.org/
en/materials/publications.html?id=55

For an introduction to the toxicity of nanoscale materials see the 
following resources:

"Size Matters" (2003), an ETC Occasional Paper which includes an 
appendix by Dr Vyvyan Howard, Founding Editor of the Journal of 
Nanotoxicology: http://www.etcgroup.org/upload/publication/165/01/
occ.paper_nanosafety.pdf

ETC Group's 2004 Communique, 'Nano's Troubled Waters'   http://
www.etcgroup.org/upload/publication/116/01/gt_troubledwater_april1.pdf

A May 2006 report on nanotechnology in sunscreens and cosmetics by 
Friends of the Earth: http://www.foe.org/camps/comm/nanotech/

A recent scientific evaluation of nanoscale hazards by the European 
Commission's highest level scientific committee on toxicity, The 
Scientific Committee on Emerging and Newly Identified Health Risks: 
http://ec.europa.eu/health/ph_risk/committees/04_scenihr/
scenihr_cons_01_en.htm

A comprehensive overview (2004) of nanoparticle toxicity, "Small 
Matter, Many Unknowns" by Swiss Re, the world's second largest re-
insurance company: http://www.swissre.com/INTERNET/pwsfilpr.nsf/
vwFilebyIDKEYLu/ULUR-5YNGET/$FILE/Publ04_Nanotech_en.pdf

Take Action:

The US Food and Drug Administration is holding its first-ever public 
hearing to discuss regulatory issues related to nanotechnology on 
October 10, 2006. Despite the fact that the US government spends 
approximately $1 billion per year on nanotech R&D and hundreds of 
consumer products are already on the market, the US government spends 
a paltry $11 million per year on nanotechnology related risk research 
(1.1% of the total budget). Go here for details: http://
www.nanotechproject.org/80/nanotechnology-development-suffers-from-
lack-of-risk-research-plan

In May 2006 ETC Group joined the International Center for Technology 
Assessment, Friends of the Earth and other consumer health and 
environmental groups in a legal petition challenging FDA's failure to 
regulate health and environmental threats from nanomaterials 
currently used in consumer products.  The full petition and an 
executive summary are available here:   http://www.icta.org/nanotech/
index.cfm

You can send electronic comments to the FDA asking them to properly 
control, regulate and label nanomaterials. An online form is 
available to help you do this via The Center for Food Safety.  Go to: 
http://ga3.org/campaign/Nano
_______________________________________________


Do you Yahoo!?
Get on board. You're invited to try the new Yahoo! Mail Beta.

#1088 From: pulsecolo <pulsecolo@...>
Date: Thu Oct 12, 2006 5:30 am
Subject: New FDA Craziness
pulsecolo
Offline Offline
Send Email Send Email
 

New FDA Craziness

 
 
An analysis by the Institute of Medicine found that the federal system for approving and regulating drugs has serious problems, and dramatic changes are required to fix them.
The report fixed the blame on the FDA, Congress, and the pharmaceutical industry, and called on all of them to share responsibility in implementing solutions.
Several of the suggested changes are ones that have been requested for many years by drug safety advocates.
Many of the recommendations would require Congressional approval to enact, including such changes as:
  • FDA commissioners would serve a single six-year term
  • Newly approved drugs would include black triangles on their labels, warning consumers their safety was still in question
  • New drugs would only be approved for five years, at which point the FDA would review their safety
  • A ban on advertising would be in effect while drugs remain on this probationary period
The panel also recommended that a substantial majority of FDA advisory panel members not have industry ties, and suggested that manufacturers should be required to produce the outcomes of all studies, not just those published in medical journals. Studies that show positive results for a drug are more likely to be published.
ABC News September 22, 2006
Washington Post September 23, 2006
Institute of Medicine September 22, 2006

New FDA Craziness

 
An analysis by the Institute of Medicine found that the federal system for approving and regulating drugs has serious problems, and dramatic changes are required to fix them
Dr. Mercola's Comment:
In an uncanny bit of timing, this scathing Institute of Medicine report came out the same day I posted news about America's dismal health care scorecard.
With the current Congressional session nearly over, there's no hope that any of these reforms will be considered before next year, when federal legislators will reconsider the existing agreement with the multi-national drug companies, under which they pay millions to speed up reviews of new drugs.
Under current law, those fees cannot be diverted to shore up the agency's woefully underfunded safety division.
Of course, the drug cartel's minister of propaganda, Pharmaceutical Research and Manufacturers of America, would have you believe any notion the FDA is seriously compromised is a big mistake.
They oppose the mandatory registration of clinical trials, arguing that this would force companies to reveal trade secrets, and they also oppose any restrictions on advertising. It's fairly easy to see where they stand on the issue of making money versus ensuring patient safety.
However, the real mistake would be trusting the FDA's opinions about drug safety, especially considering it can't even assess its own success or failure, according to Sen. Charles Grassley (R-Iowa).
We'll have to wait and see if these recommendations cause any actual changes. The drug companies significantly influence American political leaders that are responsible for FDA policies and funding. From 1998 to 2005, drug and chemical corporations spent $758 million on lobbying politicians.
In the 2004 elections alone, nearly $1 million was contributed to President Bush, $500,000 to his opponent John Kerry, and over $100,000 was contributed to approximately 18 members of Congress.
The drug and chemical industries employ over 1,200 full-time lobbyists, including 40 former members of Congress. The drug and chemical corporate lobbyists are extremely successful at what they do, which puts the FDA at the mercy of the very same chemical industry that they aim to regulate.
So, the odds are stacked against any real changes.
Don't count on the FDA. People need to take responsibility for their own health and:
  • Radically cut back on the nearly 200 pounds of sugar they eat each year
  • Stop spending 90 percent of their food money on processed foods
  • Exercise four to five times a week
  • Stop relying on drugs as Band-Aids to treat their symptoms, and demand solutions instead


Talk is cheap. Use Yahoo! Messenger to make PC-to-Phone calls. Great rates starting at 1¢/min.

#1086 From: pulsecolo <pulsecolo@...>
Date: Sun Oct 8, 2006 4:38 am
Subject: family persisted in finding doctor who would listen
pulsecolo
Offline Offline
Send Email Send Email
 

Mom seeks help for daughter stricken with mystery illness

By JAMES AMOS
THE PUEBLO CHIEFTAIN
 
Once hoping to make the 2000 U.S. Olympic taekwondo team, Raquel Roman now has a different battle on her hands.
Suffering from a possible circulatory system problem in her neck, the 26-year-old Pueblo resident suffers constant pain and recently underwent chemotherapy to try to solve it.
Her mother, Rosemary Roman, is holding a second fundraiser on Saturday, a dinner at the Circle Lounge, to try to pay for some of Raquel's mounting medical bills.
The event will be held from noon to 6 p.m. and will feature a raffle for several prizes, including a fox fur coat. Cost is $6 for adults and $4 for kids.
Raquel said her latest problems began in May when she was home visiting to watch a boxing match with her father. She'd just begun her "dream job" of being a financial adviser in Denver when she came to Pueblo with a headache and fever, which persisted.
When she told her mother she'd had the headache for four days, her mother feared meningitis, which Raquel had had before, and took her to a hospital.
Raquel stayed for the 5 weeks and began a monthslong cycle of tests, doctors and visits to hospitals here and in Denver.
Rosemary said she dismissed four doctors before finally finding one that would diagnose Raquel as having vasculitis, an inflammation of the blood vessels in Raquel's neck. Even then, no one is really sure that's what she has, and no one yet knows how to alleviate the constant pain.
Rosemary said one doctor said her daughter was faking the problem and wanted to call for psychiatric evaluation. But another doctor said Raquel was in too much pain to be faking anything.
Eventually, the family was told that chemotherapy may help Raquel. She's tried a cycle of it, but doesn't know yet if it has helped.
The medical problems have cost Rosemary $60,000 and her father another $15,000, she said. Now, she has problems paying for more tests or procedures.
A Denver hospital she was told to take her daughter to now won't treat her because she doesn't live in Denver, she said.
And Raquel said a stent placed in her because of a kidney problem can't be taken out unless she has the money for the surgery. She doesn't, and the wire-mesh tube is causing secondary infections, she said.
All this comes after Raquel was first knocked from her dream of trying for the 2000 U.S. Olympic taekwondo team by a car accident in 1999, according to her mother. The crash left her too badly injured to go on training at the Olympic Training Center in Colorado Springs, she said.
Despite being severely injured in the crash, Raquel taught herself to walk again and strengthened her body to start the next phase of her life as a financial adviser, her mother said. Then came the headache and now everything is uncertain again.
Rosemary herself has had to drop out of her studies for a nursing degree, she said.
"I couldn't afford school and take of care of her," she said. "Nobody takes care of her like I do. I've truly learned that with the hospitals."
So Rosemary said she's going to keep trying. A doctor in Penrose has offered to get Raquel tested for Lyme Disease, which can mimic other disorders, she said.
And she'd appreciate whatever help Pueblo people can extend.
"I'd be grateful for anything at this point," she said. "I am completely tapped."


Why keep checking for Mail? The all-new Yahoo! Mail shows you when there are new messages.

#1085 From: pulsecolo <pulsecolo@...>
Date: Fri Oct 6, 2006 5:00 am
Subject: Fwd: Jim and Joan Clarke's Demonstration at Johns Hopkins this morning and afternoon.
pulsecolo
Offline Offline
Send Email Send Email
 

From Bill


Dear Friends. I was able to attend the press conference and
demonstration by 15 persons and the Clarkes. Johns Hopkins knew we
were there. There was security everywhere.

Joan addressed a small crowd on public property in front of Johns
Hopkins Hospital entrance on Wolfe Street in Baltimore. Two TV
cameras were grinding and a few press photographers were
present. Due to the activity on the street, we didn't have much of
an opportunity to meet one another. I didn't recognize others in our
group except the Clarke's.

About a half a dozen executives, including a Hopkins' VP, watched all
our moves. Jim used a megaphone later, but was warned by a Baltimore
cop to desist. Jim quit. One VP tried to stop me from going into
the parking area in front of the main entrance. He told me it was
private property. I told him I was going to the restroom in the main
building. He said I was denied entry. I said, sorry I am going
anywhere that I liked on Hopkins' property, because I was a Johns
Hopkins' patient and I showed him my JHH ID "orange card". He bade
my pardon and I went on.

When I spotted these guys, I took five or six photographs of them
standing around, just to tick them off.

The lunch traffic at the entrance to the hospital slackened by
1:30. I left shortly thereafter. Others, including the Clarke's, remained.
Jim and Joan were most kind and considerate to all of us. Joan said
she and Jim were going to do it again.

That's it. No arrests, no scuffles with cops, no broken windows -
just alot of not and disruption during a few hours in front of Johns
Hopkins. Will Hopkins administrators respond? Probably not, but it
won't stop, until they do.

Good job, Joan and Jim. Take care of yourselves. Many others are
following what happened today.

Bill
Wright, justapatient



Why keep checking for Mail? The all-new Yahoo! Mail shows you when there are new messages.

#1084 From: pulsecolo <pulsecolo@...>
Date: Sun Oct 1, 2006 6:27 pm
Subject: Finally, for the people, by the people, of the people.. Demonstration against substandard medical care.
pulsecolo
Offline Offline
Send Email Send Email
 

Please attend or send someone you know who lives in the region, this is more important then you think it is.   This is the ONLY way to change things.  There is NO other way... 


Patients' Rights Trampled as Medical Negligence Spreads to Epidemic Proportions; Press Conference and Demonstration, October 4

People Against Medical Malpractice (PAMM) supports the “Patients’ Bill of Rights,” the public’s “Right To Know,” and the National MEDiC Act.
 
Contact: Jim and Joan Clarke, 610-421-8300, Factfinders27@...
 
BALTIMORE, Sept. 28 /Christian Newswire/ -- The Patients’ Bill of Rights provides the patient with the right to have access to appropriate high-quality health care, the right to know all their treatment options and to participate in decisions about their care, the right to review and copy their own medical records and request the physician amend their record if it is not accurate, relevant, or complete. Finally, the patient has the right to a fair, fast and objective review of any complaint they have against the healthcare provider.

However, the Patients’ Bill of Rights does not provide for the unsafe conditions in hospitals caused by the preventable medical negligence which kills 195,000 people annually and maims and catastrophically disables countless hundreds of thousands more. “Wrongful deaths” from preventable medical negligence kills patients at the rate of 23 per hour, while the homicide rate in this country is only 2 people per hour.

People have the right to:
 
  • Know whether doctors and hospitals have a history of causing catastrophic harm,
     
  • Legal representation free from sabotage due to lawyer pay-offs from hospitals,
     
  • A full investigation by their State Attorney General into the violations of state criminal and civil laws by any healthcare provider,
     
  • Know that doctors and hospitals that violate federal and state laws will be subject to legal action against them by federal and state prosecutors,
     
  • Know if a healthcare provider alters or destroys their medical records,
     
  • Know the identity and medical specialty of each attending physician,
     
  • Know the infectious disease rate in any hospital that they go to for treatment,
     
  • Know about the “Patient Blacklist” doctors maintain on people who try to recover damages from devastating injuries incurred at the hands of doctors and hospitals,
     
  • Know that the medical delivery system (hospitals and doctors) has morphed into a system that is no longer on their side,
     
  • Know that most doctors routinely assist negligent doctors to cover-up the harm done to people in hospitals,
     
  • Know that state and federal agencies often will not help them investigate and prosecute these criminal activities.
People must now demand that doctors and hospitals be subject to the same laws as everyone else i.e. when they cause egregious harm, punishment must apply to them as it would to anyone else.

People Against Medical Malpractice (PAMM) supports the National MEDiC Act which is designed to establish a National Medical Error Disclosure and Compensation (MEDiC) Program. The goal of the MEDiC Program is to: (1) improve the quality of health care by encouraging open communication between patients and health care providers about medical errors and other patient safety events; (2) reduce the rates of preventable medical errors; and (3) ensure patients have access to fair compensation for medical injury due to medical error, negligence, or malpractice.

People Against Medical Malpractice (PAMM) is organizing a patient safety demonstration in front of Johns Hopkins Hospital, located at 600 North Wolfe Street in Baltimore, Maryland, to sound the alarm to the ever-growing danger that exists in our American hospitals. On Wednesday, October 4, 2006 (rain date October 11th) there will be a press conference at 11:30am and the demonstration will follow immediately.
 
Press Conference and Demonstration Details ---
 
When: Wednesday, October 4, 2006, 11:30 AM
 
Where:  Johns Hopkins Hospital, 600 North Wolfe Street, Baltimore
 
This demonstration is a “Call to Arms” for the public to speak out with their signs, pictures and voices and to demand safer hospitals, accountability from doctors and hospitals, and justice from the Courts!


Talk is cheap. Use Yahoo! Messenger to make PC-to-Phone calls. Great rates starting at 1¢/min.

#1083 From: pulsecolo <pulsecolo@...>
Date: Thu Sep 21, 2006 4:16 pm
Subject: re. Demonstration Oct. 4th
pulsecolo
Offline Offline
Send Email Send Email
 
For the past week or so, I have heard from some of you regarding the demonstration at Hopkins on Oct. 4.  I have not responded to anyone individually and will try my best to address everyones concerns here and now.    
 
  1.  Yes,  "Hopkins might well be the safest hospital in the nation", but bad things still go wrong there and sadly, the bad outcomes are not addressed as they should be.   So, if this is the best hospital in our country, consider the worst, not to mention  all of the other hospitals somewhere in the middle.  
 
2.   "This hospital is not the one that  caused my loss".   As a symbol for all of the broken hearts and shortened lives, or lives altered forever by this epidemic, this demonstration will tell the public that we are outraged and  tired of this needless suffering.  There are nearly 200,000 preventable deaths per year from medical errors, this does not include other outcomes that cause iatrogenic injury or death which bring the numbers up substantially.    
 
3. " Hopkins has a great policy on disclosure" , apparently not all the time or the Clarkes would not be doing this.
 
4.   Someone might see me there and and this will "undo" all the good I have done in patient safety.     There is apparently not enough good.   My mother has been dead for 11 years, I have been  patiently trying to work within the system to help change it for nearly 8 of those years.   Yes, many wonderful and dedicated people are on the inside trying to change the system, but there are NOT enough of them.   They need our help as a society demanding better quality, transparency and truth at all costs to recruit others to help them make the changes needed.    They need our help in cleaning up their house now.       A peaceful demonstration will tell all Americans that we must have 0 tolerance for medical errors, nothing less is good enough for our country. 
 
5. " I don't even know these people, I cannot protest for them" .   You are NOT protesting for them, you are protesting for you, for all Americans, and for the millions dead and injured by this monster that no one seems to know how to tame.  
 
 
6.   "This is not about tort reform".   In a way it is,  you see, stopping the iatrogenic injury and death is by far the most effective way to deal with the tort reform issue.    
 
 
The Clarkes are brave people who have the courage to do this, please support them.
Our society is in denial, this demonstration will open many eyes, the press covers large demonstrations, not small ones.   
 
Please reconsider attending this demonstration, the more faces, the more impact.   Below is the press release....
 
For Immediate Release CONTACT:
> > > September 4, 2006 Jim and Joan
> > > Clarke
> > > Factfinders27@...
> > > 610-421-8300
> > >
> > >
> > > PEOPLE AGAINST MEDICAL MALPRACTICE OPPOSES JOHNS
> > > HOPKINS ALTERING
> > > AND DESTROYING MEDICAL RECORDS TO AVOID
> > > ACCOUNTABILITY
> > >
> > > Which is safer for you, being in the streets of
> > any
> > > city in the country or
> > > being in any hospitals in these cities?
> > >
> > > Nearly 195,000 people in the US died each year
> as
> > a
> > > result of preventable
> > > medical errors in 2000, 2001, 2002 according to
> a
> > > study of 37 million patient
> > > records that was released by HealthGrades, the
> > > leading healthcare rating
> > > organization (www.healthgrades.com).
> > >
> > > In the FBI Uniform Crime Report 2002 for all US
> > > cities, the total number of
> > > homicides was 16,204.
> > >
> > > Comparing this information, we find the
> following
> > > statistics:
> > >
> > > Preventable Deaths in Hospitals
> > > Homicides
> > > 195,000 per year 16,204 per year
> > > 534 per day 44 per day
> > > 23 per hour 2 per hour
> > >
> > > The answer to the question is you are safer in
> the
> > > streets of any city in the
> > > US than in any of our hospitals.
> > >
> > > Missing from this data are the countless
> thousands
> > > of patients each year who
> > > are maimed and catastrophically disabled by
> > > preventable medical errors.
> > > These victims and their families suffer severe
> > > physical, emotional, and economic
> > > ruin for the rest of their lives.
> > >
> > > It is time for these victims and their families
> to
> > > have a public voice and
> > > speak out about the permanent damages they
> suffer
> > > at the hands of these
> > > medical criminals.
> > >
> > > People Against Medical Malpractice (PAMM) is
> > > organizing a patient safety
> > > demonstration in front of Johns Hopkins
> Hospital,
> > > located at 600 North Wolfe
> > > Street in Baltimore, Maryland, to sound the
> alarm
> > > to the ever-growing danger
> > > that exists in our American hospitals. On
> > > Wednesday, October 4, 2006 (raindate
> > > October 11th) there will be a press conference
> at
> > > 11:30am and demonstration
> > > follows immediately.
> > >
> > > This particular hospital system has proven
> itself
> > > to be especially
> > > dangerous, nearly deadly to our family. They
> have
> > > evaded all responsibility. We are
> > > urging hospital victims to join us in making a
> > > stand against these
> > > atrocities.
> > >
> > > Please use this opportunity to make a difference
> > in
> > > your life and the lives
> > > of others who will become victims of preventable
> > > medical errors.
> > >
> > > Share this email with everybody in your address
> > > book. There is strength in
> > > numbers.
> > >
> > > To participate in the demonstration, email us by
> > > September 27, 2006 of your
> > > intention at: Factfinders27@...
> > >
> > > Your participation is important.
> > >
> > > We will see you in front of Johns Hopkins
> Hospital
> > > on October 4th.
> > >


All-new Yahoo! Mail - Fire up a more powerful email and get things done faster.

#1082 From: pulsecolo <pulsecolo@...>
Date: Thu Sep 21, 2006 3:15 am
Subject: Fwd: HIV in children from dirty care!
pulsecolo
Offline Offline
Send Email Send Email
 


g_upham <g_upham@...> wrote:
Date: Wed, 20 Sep 2006 19:48:26 +0200
From: g_upham <g_upham@...>
To: pulsecolo@...
Subject: HIV in children from dirty care!

Dear friends,
You know my engagement against dirty injections in health care,
Dr Modibo Dicko had told the 2004 World Health Assembly, in presenting
the WAPS program that injection safety was priority for WHOAFRO
considering the presence of HIV. I was shocked to get these news
yesterday See below (the news item below was all over the international
media, this one if from POZ, the US based publication of people with HIV).
- for those interested, a scientific publication I co-authored -that
appeared early September, in one of the scientific publication on
hospital infection control, makes at attempt at re-evaluating the risk
of HIV transmission, in /Infection Control and Hospital Epidemiology/,
volume 27 (2006), pages 944952.
Up to now the efficiency of HIV transmission through dirty medical
procedures was calculated from accidents of Health Care Workers, and
never from the risk posed to patients by dirty injections- 9 billion a
year, etc. Of course, this publication is in my own name with my company
and P4PS is not mentioned.
web:
http://www.journals.uchicago.edu/cgi-bin/resolve?id=msid:ICHE2004299&erFrom=-3759256792263992486Guest
I have full article in pdf for those interested.
see also below an August publication on women in Zambia contracting HIV
through dirty care.


49 Children Infected With HIV in Kazakhstan Hospital

Created: 08.09.2006 14:54 MSK (GMT +3), Updated: 15:15 MSK* *

MosNews

Kazakh authorities say at least 49 children have been infected with HIV
in hospitals in the south of the country, Radio Free Europe reported on
Friday. Authorities in Shymkent instigated wide-scale testing after the
discovery in July that 14 children had been inflected. They believe the
children were infected with the virus by non-sterilized syringes, or
transfusions of contaminated blood in three separate childrens
hospitals in the area.

The Kazakh Health Ministry confirmed the new figure in a statement,
saying more than 6,000 children remained to be tested for HIV in the region.
Kazakh parliamentarian Yerasyl Abylkasymov on September 6 said he had
asked the prosecutor-generals office to prosecute Southern Kazakhstan
Regions health and administration officials.

references documenting HIV and dirty injections in Africa:

Factors associated with HIV prevalence in a pre-partum
cohort of Zambian women
Authors: St Lawrence, J.S.1; Klaskala, W.2; Kankasa,
C.3; West, J.T.2; Mitchell, C.D.4; Wood, C.2

Source: International Journal of STD & AIDS, Volume
17, Number 9, September 2006, pp. 607-613(7)

Publisher: Royal Society of Medicine Press

Abstract:

An ongoing study of mother-to-child human herpes
virus-8 (HHV-8) transmission in Zambian women (n =
3160) allowed us to examine the association of medical
injections with HIV serostatus while simultaneously
accounting for other factors known to be correlated
with HIV prevalence. Multi-method data collection
included structured interviews, medical record
abstraction, clinical examinations, and biological
measures. Medically administered intramuscular or
intravenous injections in the past five years (but not
blood transfusions) were overwhelmingly correlated
with HIV prevalence, exceeding the contribution of
sexual behaviours in a multivariable logistic
regression. Statistically significant associations
with HIV also were found for some demographic
variables, sexual behaviours, alcohol use, and
sexually transmitted diseases (STD). The results
confirmed that iatrogenic needle exposure, sexual
behaviour, demographic factors, substance use, and STD
history are all implicated in Zambian women's HIV +
status. However, the disproportionate association of
medical injection history with HIV highlights the need
to investigate further and prospectively the role of
health-care injection in sub-Saharan Africa's HIV
epidemic.
>
>
>
>



Yahoo! Messenger with Voice. Make PC-to-Phone Calls to the US (and 30+ countries) for 2/min or less.

#1081 From: pulsecolo <pulsecolo@...>
Date: Mon Aug 21, 2006 5:53 am
Subject: Hospitals Bilking & Milking The Medicare System For Billions
pulsecolo
Offline Offline
Send Email Send Email
 

 
August 20, 2006
Hospitals Grew With Medicare Paying the Way
LIVINGSTON, N.J. — The St. Barnabas hospital system spent much of the last decade in a sprint to expand through aggressive mergers, political connections and celebrity patrons like the actor Joe Pesci, growing into New Jersey’s largest health care provider and the state’s second biggest private employer.
But the rapid rise in the prominence of St. Barnabas — which at one time had 3,200 beds in nine hospitals throughout the state — was also fueled by what federal prosecutors called one of the most lucrative Medicare fraud schemes in the nation’s history.
By systematically inflating the bills for their sickest elderly patients, the prosecutors said, the executives of the St. Barnabas Health Care System bilked the federal government of at least $630 million from 1995 to 2003. The hospital system, which is a nonprofit institution, eventually stopped the overcharging when it was publicly questioned, and in June the hospital system and its executives, who had been threatened with criminal prosecution, agreed to repay the federal government $265 million.
St. Barnabas has rejected allegations that it defrauded Medicare. In the settlement, it did not acknowledge any deliberate wrongdoing, and last week, Ellen Greene, a spokeswoman for St. Barnabas, described the situation as the result of a misinterpretation of Medicare’s complex rules. She said the company was glad to have gotten past the problem and was focusing on its health care mission.
What happened at this health care system, based largely in suburbs throughout New Jersey, is representative of how hundreds of hospitals around the country, facing pressures from cuts in reimbursements by private insurers, improperly charged the taxpayer-financed Medicare program billions of dollars.
The episode at St. Barnabas, whose legal problems are not over, is part of a wave of Medicare fraud investigations that, according to a federal report, have reached more than 450 hospitals nationwide. Experts said the money involved could exceed $6 billion.
“The way the system has operated, it’s almost irresponsible corporate governance for hospitals not to cheat Medicare,” said Patrick Burns, an analyst at Taxpayers Against Fraud, a leading watchdog organization.
The problems began a decade ago, when hospital administrators around the country —facing cuts in reimbursements from managed care companies — turned to a handful of accounting firms that promised to help them maximize their financing from Medicare, the nation’s health insurance program for the elderly.
By exploiting loopholes in the complex formula that Medicare uses to reimburse providers for their most expensive cases, known as outliers, many hospitals’ federal aid doubled, quadrupled or increased 10 times.
St. Barnabas received more federal Medicare money from the pool of outlier money than some national chains 10 times its size. In 2001, the aid accounted for more than 15 percent of St. Barnabas’s total revenue, at least five times a typical percentage, and, according to depositions from former employees, the hospital system’s bookkeepers were ordered to hide the money elsewhere in the budget to avoid arousing the suspicions of auditors.
Ms. Greene declined to comment on that allegation.
Fearing that a harsher fine might run the St. Barnabas health care system out of business, federal prosecutors said St. Barnabas had been required to pay back less than half of the amount it overbilled.
A few weeks after the government case against St. Barnabas was settled, Tenet Healthcare, one of the nation’s largest hospital chains, agreed to repay $788 million of the $1.9 billion it had been accused of overcharging. No one involved in either case faced criminal charges.
After their Medicare subsidies shrank, both St. Barnabas and Tenet closed hospitals, costing hundreds of employees their jobs and disrupting medical care for the communities they had served. Still, in New Jersey, where state officials are impaneling a commission to close a dozen or more hospitals, St. Barnabas finds itself in a far stronger financial position than many hospitals that were not suspected of skirting the law.
As recently as the early 1990’s, St. Barnabas — which was named after a martyr who sold his possessions to help the poor, but is not run by the Roman Catholic Church — operated with a low-key business approach usually found at institutions that are licensed as nonprofit.
Faced with pressure from managed care insurance plans and the prospect of federal health care reform, the system’s chief executive, Ronald J. Del Mauro, voiced determination to firm up St. Barnabas’s financial stability. He preached a strict devotion to the bottom line and engineered a bold set of mergers and acquisitions.
By 1996, St. Barnabas ran seven hospitals in northern and central New Jersey, with 4,000 affiliated doctors, more than 20,000 employees and a million patients. According to depositions by a St. Barnabas consultant and two former employees, which were filed in the settlement, the drive for profits soon affected the Medicare billing, and hospital administrators found a way to capitalize on a loophole in the formula Medicare used to determine reimbursements in outlier cases.
One part of the equation was based on a hospital’s retail charges: the amount paid by the small percentage of patients who do not have insurance. By rapidly increasing retail charges for procedures often covered by Medicare, St. Barnabas got a steep increase in federal aid. As a result, its Medicare payments for outlier cases jumped to $287 million in 2002 from $85 million in 1998.
A consultant hired to work with St. Barnabas said in a sworn deposition that the hospital’s top executives held meetings to plan a “corporate directive” to increase federal aid by raising the prices charged to Medicare patients. The consultant, James T. Monahan, said that St. Barnabas had routinely added hidden charges to the room-and-board fees of Medicare patients and tried to conceal the windfall profits it was receiving from Medicare, in part by overstating its debt.
Mr. Monahan, who later filed a whistle-blower complaint under which he stands to gain millions of dollars from the legal settlement, declined to be interviewed for this article.
St. Barnabas was hardly alone in that practice. Hundreds of other hospitals were using similar tactics to artificially boost their Medicare payments, and many were clients of two accounting firms that specialized in helping clients do that.
The fraud was so extensive, Medicare officials said in 2003, that to restrict the number of outlier claims, they had to raise the threshold for qualified cases in each of the previous five years: from under $10,000 in 1998, to more than $33,000 in 2003.
Despite the years-long surge in questionable Medicare payments across the country, federal auditors did not undertake a widespread investigation until October 2002, when Kenneth R. Weakley, an analyst for UBS Warburg, wrote a report warning investors that Tenet was receiving an “extraordinary” and unsustainable amount of outlier financing.
As they announced the settlements with Tenet and St. Barnabas in June, Justice Department officials said they were satisfied that they had collected a substantial sum of money without risking an uncertain outcome at trial and without endangering the viability of the two hospital systems. David Knowlton, executive director of the New Jersey Health Care Quality Institute, an advocacy group, said that even though the settlements did not recover all the fraudulently obtained funds, they would provide a strong deterrent.
Officials of St. Barnabas pointed out that they had not admitted any wrongdoing and said they were relieved to be able to focus their attention on health care without the distraction of an investigation.
“This agreement,” Michael Slusarz, a vice president and spokesman for St. Barnabas, said in a statement in June, “will allow us to focus our energy and resources on our mission of providing the highest quality of care to our patients.”
As the state begins deciding how many, and which, hospitals to close, St. Barnabas is in an enviable position by virtue of its size, its reputation for providing quality health care and its political contacts in Trenton. For instance, the state’s health commissioner, Fred Jacobs, was senior vice president of medical affairs at St. Barnabas before being appointed to his current post, and Gov. Jon S. Corzine’s deputy chief of staff, Jeaninne LaRue, was a senior vice president and lobbyist for St. Barnabas. The company has also had a long relationship with Senate President Richard J. Codey, whose district in Essex County has some St. Barnabas facilities. During Mr. Codey’s 14 months as acting governor, his administration approved St. Barnabas’s application to perform highly profitable angioplasty procedures without having a cardiac surgical backup, an arrangement that some health care advocates criticized as favoritism. Mr. Codey insists that the decision was made based on the recommendations of a committee of health care experts, and that he was not personally involved.
“I certainly try to support the hospital, because it’s important for the community and a large employer, but there’s nothing more to it than that, ” he said.
St. Barnabas continues to face legal scrutiny, however.
A class-action suit filed by two hospitals, one from Colorado and one from Maine, claims $514 million in damages because the overbilling by St. Barnabas deprived “all of the legitimate hospitals of aid they were entitled to,” said Hal Hirsch, a lawyer for the plaintiffs. Wall Street rating agencies downgraded St. Barnabas bonds after the government settlement was signed and the hospitals’ lawsuit was filed.
Hundreds of nonprofit hospitals across the country are being scrutinized by the Internal Revenue Service and examined by Congress to determine whether they are following guidelines that forbid tax-exempt entities to give executives excessive compensation.
The United States attorney’s office in New Jersey declined to comment on whether the executive pay structure at St. Barnabas was part of any inquiry. But two people who had been questioned by Justice Department investigators said they had been asked for documentation on how Mr. Del Mauro and two other top administrators at St. Barnabas are paid.
Mr. Del Mauro gets no compensation from St. Barnabas Hospital Center, according to its public filings, but he and two other senior administrators are paid officers of SBC Management, a profit-making company that does business with the hospital center. That sort of arrangement is common in the hospital industry.
In 1998, Mr. Del Mauro received $613,000 from SBC, according to documents on file with the I.R.S. His compensation was $4.7 million in 2003, the last year St. Barnabas received the huge Medicare overpayments. In 2004, it was $4.2 million.
Speaking on Mr. Del Mauro’s behalf, Ms. Greene, vice president for public relations and marketing at St. Barnabas, said that she was unable to provide details about Mr. Del Mauro’s compensation or the amount and type of business transactions between the hospital and SBC Management, but that the hospital was complying with the law and the federal tax code.


Do you Yahoo!?
Get on board. You're invited to try the new Yahoo! Mail Beta.

#1080 From: pulsecolo <pulsecolo@...>
Date: Tue Aug 15, 2006 6:58 am
Subject: Better standards can thwart drug deaths
pulsecolo
Offline Offline
Send Email Send Email
 
http://www.usatoday.com/news/opinion/editorials/2006-08-13-letters-drugs
-ney-stone_x.htm
Better standards can thwart drug deaths
Posted 8/13/2006 10:20 PM ET E-mail | Save | Print | Subscribe to stories like this Subscribe to stories like this
There are many lessons to be learned from the tragic death last summer of a cardiac patient at a Fredericksburg, Va., hospital, where bacterial contamination of an injected surgical solution is the suspected culprit. Paramount among these, however, is that the incident and others like it are entirely preventable (" Deaths spur debate about drugs made in pharmacies," Cover story, News, Tuesday).
Compounding by pharmacists when best-practice standards for quality assurance, safety and efficacy are applied and adhered to is instrumental in meeting the special needs of patients when commercially available products can't.
For more than 60 years, the American Society of Health-System Pharmacists has led medication-use improvements, including developing evidence-based practice standards and guidelines in the area of sterile and non-sterile compounding.
To further ensure the quality of compounded medications, it is imperative that pharmacists and pharmacy technicians be adequately trained and have sufficient facilities and equipment that meet technical and professional standards. When hospitals and other care settings outsource some aspects of pharmacy services, such as sterile compounding, those organizations and their pharmacy departments must share the accountability for patient outcomes stemming from all medication-related activities performed by contractors on- or off-site.
The onus should not fall solely on the hospital. The fact that Central Admixture Pharmacy Services, the business hired by the Virginia hospital to produce the cardiac surgery drug, is a Food and Drug Administration-registered facility suggests that a re-examination of the regulatory framework of commercial, large-scale operations that compound sterile products for hospitals is in order.
While the culprit in the tragic death of the cardiac patient is not yet definitively known, the merits of best practices and evidenced-based compounding are a well-established fact.
Henri R. Manasse Jr.
Executive vice president, CEO of American Society of Health-System Pharmacists
Bethesda, Md.


Stay in the know. Pulse on the new Yahoo.com. Check it out.

#1079 From: pulsecolo <pulsecolo@...>
Date: Tue Aug 15, 2006 6:53 am
Subject: Bipartisan Legislation to Create Special Health Courts is Introduced in U.S. Senate
pulsecolo
Offline Offline
Send Email Send Email
 
Would very much like some discussion about this possible legislation.   
 
 

Bipartisan Legislation to Create Special Health Courts is Introduced in U.S. Senate

The Bill, Advancing an Idea Championed by Common Good, Would Authorize Funding for States to Create Health Courts on a Pilot Project Basis
Common Good Press Release, June 30, 2005
Senators Michael Enzi (R-WY) and Max Baucus (D-MT) have introduced legislation in the U.S. Senate to create special health courts on a pilot project basis. Known as the Fair and Reliable Medical Justice Act, the bill is backed by a broad coalition of patient advocates and providers and responds to the Institute of Medicine's call for the development of alternatives to current medical tort litigation. Sen. Enzi is Chair of the Senate Committee on Health, Education, Labor, & Pensions. Committee hearings on the legislation occurred on June 22nd, 2006.  Read more about the hearings here.
 
The bill's purpose is:
  • To restore fairness and reliability to the medical justice system by fostering alternatives to current medical tort litigation, including the creation of a special health care court, that promote early disclosure of health care errors and provide prompt, fair, and reasonable compensation to patients who are injured by health care errors;
  • To promote patient safety through early disclosure of health care errors; and
  • To support and assist states in developing such alternatives.
The bill would authorize the U.S. Secretary of Health and Human Services to award up to 10 demonstration grants to states for the development, implementation and evaluation of alternatives to current tort litigation for resolving disputes over medical errors. Within that context, the bill specifically authorizes the creation of a special health care court. The hallmark of such a court would be full-time judges with health care expertise, whose sole focus would be on addressing medical malpractice cases.
"This important bill, introduced by Senators Enzi and Baucus, points the way to making justice in health care serve our common goals," said Philip K. Howard, Chair of Common Good. "Special health courts can offer reliable justice for doctors and patients alike, while providing affirmative rulings to improve patient safety. Both Senators deserve great praise for advancing this bipartisan initiative."
"Reliable and timely decisions by expert courts are needed for real improvements in patient safety, as well as basic fairness," said Troyen Brennan, MD, M.P.H., a Professor at the Department of Health Policy and Management at Harvard School of Public Health. "The important legislation introduced by Senators Enzi and Baucus is a very significant step in the right direction."
"The current medical liability system incentivizes cover-up and blame, fueling the epidemic of medical error," said Martin J. Hatlie, President of the Partnership for Patient Safety. "The legislation introduced by Senator Enzi and Senator Baucus can help create the system of justice that both consumers and providers need to restore trust between them, improve health care and save lives."
"Health courts are needed to provide fair resolution to both patients and health care providers," said William L. Roper, M.D., M.P.H., Dean of the School of Medicine and CEO of the University of North Carolina Health Care System. "The legislation introduced by Senators Enzi and Baucus represents an important step in developing a more reliable system of medical justice."
More than 80 of the nation's most prominent leaders in health care and law--including patient safety experts and 11 deans of medical schools or schools of public health--have called for the creation of special health courts as a way of restoring reliability to medical justice. Their call was precipitated by inadequacies and inequities in the current system:
  • At present, less than two percent of patients with medical injuries due to substandard care file a claim, and even fewer receive compensation. Those fortunate enough to receive compensation will have waited an average of four years in the court system before receiving a dime.
  • The current system cannot reliably distinguish good doctors from bad ones, which exposes medical professionals who have done nothing wrong to the risk of ruinous liability. Eighty percent of claims involve situations where doctors did no wrong. Nonetheless, plaintiffs receive compensation in a quarter of these cases.
  • The current system harms patient quality and safety. Fear of litigation drives costly and inefficient "defensive medicine," while creating incentives for health care providers to cover up their own mistakes and the mistakes of their colleagues. This culture of silence prevents doctors from learning from mistakes, and leads to needless suffering and death.


Do you Yahoo!?
Everyone is raving about the all-new Yahoo! Mail Beta.

#1078 From: pulsecolo <pulsecolo@...>
Date: Tue Aug 1, 2006 1:08 am
Subject: assistance needed
pulsecolo
Offline Offline
Send Email Send Email
 
Does anyone know of any agency other then AHRQ and NPSF, that has
research data on consumer perception and engagement in patient safety?   Data from other countries would help as well.  Any assistance that you can give will be greatly
appreciated.   Thank you so much in advance for your help in this. 
 
Best,
 
Jennifer Dingman
PULSE


Open multiple messages at once with the all new Yahoo! Mail Beta.

#1077 From: pulsecolo <pulsecolo@...>
Date: Sat Jul 29, 2006 2:17 am
Subject: Update on JAMA's Conflict of Interest Policy
pulsecolo
Offline Offline
Send Email Send Email
 
 
Update on JAMA's Conflict of Interest Policy
Annette Flanagin, RN, MA; Phil B. Fontanarosa, MD, MBA; Catherine D. DeAngelis, MD, MPH
JAMA. 2006;296:220-221.
Since the mid-1980s, JAMA and other medical journals have encouraged authors to disclose conflicts of interest that they may have in the subject matter of their manuscripts.1 In 1989, JAMA began requiring authors to sign a statement declaring all potential financial conflicts of interest and began including all such disclosures in published articles.2 Since that time, the journal's conflict of interest policy has continued to evolve with the goal of improving disclosures and transparency for all involved.3-4 For example, the policy applies to all types of manuscripts, including letters and book reviews, and to all individuals involved in the review, editorial evaluation, and publication process, including peer reviewers, editorial board members, and editors. Most recently, JAMA began requiring authors to specifically indicate if they have no conflicts of interest in the subject matter of their manuscript.4 The International Committee of Medical Journal Editors (ICMJE),5 the Council of Science Editors (CSE),6 and the World Association of Medical Editors (WAME)7 have similar policies.
However, biomedical journals have a wide range of conflict of interest policies (eg, some request disclosures, some require disclosures, and some publish disclosures and some do not).8-9 Journals also define relevant conflicts of interest in different terms to include financial and nonfinancial conflicts or only financial interests, and for financial interests, may define relevance in different monetary amounts or lengths of time. Perhaps because of these different policies, some authors may not fully understand JAMA's requirements for reporting potential conflicts of interest and might not fully disclose their conflicts of interest to JAMA at the time they submit their manuscripts. For example, some authors completely disclose all relevant conflicts of interest in the submitted manuscript, whereas other authors disclose relevant interests in a cover letter or only in the authorship form. The result is an inconsistent approach whereby for some authors, the disclosure is completely transparent to all involved in the manuscript evaluation process, including peer reviewers; but for other authors, the disclosure is made public only at the time of publication. In addition, some authors continue to misunderstand what is expected and provide inaccurate or incomplete disclosures that are discovered after publication and result in a published correction or letter of explanation.10-14
To further improve the transparency of reporting of potential conflicts of interest and to encourage more accurate and complete disclosures, an important new policy is that JAMA will begin requiring all authors to disclose all potential conflicts of interest in the Acknowledgment section of the manuscript at the time of submission. This includes specific financial interests and relationships and affiliations relevant to the subject of the manuscript. Between now and the end of 2006, JAMA will permit submissions of manuscripts in which authors' conflict of interest information is not yet included in the manuscript, but with the understanding that this information will be obtained and submitted promptlyand definitely before any revisions are considered. Beginning January 2007, JAMA will require that complete disclosures of conflicts of interest from all authors, including declaration of no conflicts of interest, are included in the Acknowledgment section of the manuscript. JAMA's Web-based manuscript submission system will require the corresponding author to indicate that this information is included in the manuscript at the time of submission. Authors will continue to complete and sign an authorship responsibility form that includes statements on conflict of interest as well as funding and support.
Conflicts of interest in biomedical science continue to be under intense and increasing scrutiny. To help ensure transparency and complete reporting of this information, JAMA's policies on conflicts of interest have been updated (as noted below).15 All authors are encouraged to read these policies carefully and to follow them completely. By doing so, peer reviewers and editors can expect full disclosure of potential conflicts of interest in manuscripts submitted to JAMA, and physicians, other health care professionals, and the public can expect complete reporting of conflict of interest information in articles published in JAMA.
JAMA Conflict of Interest Policy

"A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships or affiliations that could influence (or bias) the author's decisions, work, or manuscript. All authors are required to disclose all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. Authors should err on the side of full disclosure and should contact the editorial office if they have questions or concerns.
All such disclosures should be listed in the Acknowledgment section at the end of the manuscript. Authors without conflicts of interest, including specific financial interests and relationships and affiliations relevant to the subject of their manuscript, should include a statement of no such interests in the Acknowledgment section of the manuscript. Failure to include this information in the manuscript may delay evaluation and review of the manuscript.
Authors are expected to provide detailed information about all relevant financial interests and relationships or financial conflicts within the past 5 years and for the foreseeable future (eg, employment/affiliation, grants or funding, consultancies, honoraria, stock ownership or options, expert testimony, royalties, or patents filed, received, or pending), particularly those present at the time the research was conducted and through publication, as well as other financial interests (such as patent applications in preparation) that represent potential future financial gain. Although many universities and other institutions have established policies and thresholds for reporting financial interests and other conflicts of interest, JAMA requires complete disclosure of all relevant financial relationships and potential financial conflicts of interest, regardless of amount or value. For example, authors of a manuscript about hypertension should report all financial relationships they have with all manufacturers of products used in the management of hypertension, not only those relationships with companies whose specific products are mentioned in the manuscript. If authors are uncertain about what constitutes a relevant financial interest or relationship, they should contact the editorial office.
For all accepted manuscripts, each author's disclosures of conflicts of interest and relevant financial interests and affiliations and declarations of no such interests will be published. Decisions about whether such information provided by authors should be published, and thereby disclosed to readers, are usually straightforward. Although editors are willing to discuss disclosure of specific conflicts of interest with authors, JAMA's policy is one of complete disclosure of all potential conflicts of interest, including specific financial interests and relationships and affiliations (other than those affiliations listed in the title page of the manuscript) relevant to the subject of their manuscript. The policy requesting disclosure of conflicts of interest applies for all manuscript submissions, including letters to the editor and book reviews. If an author's disclosure of potential conflict of interest is determined to be inaccurate or incomplete after publication, a correction will be published to rectify the original published disclosure statement.
Authors also are required to report detailed information regarding all financial and material support for the research and work, including but not limited to grant support, funding sources, and provision of equipment and supplies in the Acknowledgment section of the manuscript.
All authors must also complete and sign a statement on financial disclosures, funding, and support that is part of the Authorship Form."

AUTHOR INFORMATION

Financial Disclosures: None reported.
Editorials represent the opinions of the authors and JAMA and not those of the American Medical Association.
Author Affiliations: Ms Flanagin (annette.flanagin@... ) is Managing Deputy Editor, Dr Fontanarosa is Executive Deputy Editor, and Dr DeAngelis is Editor in Chief, JAMA.

REFERENCES

1. Lundberg GD, Flanagin A. New requirements for authors: signed statements of authorship responsibility and financial disclosure. JAMA. 1989;262:2003-2004. FULL TEXT | ISI | PUBMED
2. Rennie D, Flanagin A, Glass RM. Conflicts of interest in the publication of science. JAMA. 1991;266:266-267. FULL TEXT | ISI | PUBMED
3. DeAngelis CD, Fontanarosa PB, Flanagin A. Reporting financial conflicts of interest and relationships between investigators and research sponsors. JAMA. 2001;286:89-91. FREE FULL TEXT
4. Fontanarosa PB, Flanagin A, DeAngelis CD. Reporting conflicts of interest, financial aspects of research, and role of sponsors in funded studies. JAMA. 2005;294:110-111. FREE FULL TEXT
5. International Committee of Medical Journal Editors. Uniform requirements for manuscripts submitted to biomedical journals: updated October 2005. http://www.icmje.org. Accessibility verified June 15, 2006.
6. Council of Science Editors. Conflicts of interest and the peer review process. http://www.councilscienceeditors.org/services/draft_approved.cfm. Accessibility verified June 15, 2006.
7. World Association of Medical Editors. WAME recommendations on publication ethics policies for medical journals. http://www.wame.org/pubethicrecom.htm. Accessibility verified June 15, 2006.
8. Krimsky S, Rothenberg LS. Conflict of interest policies in science and medical journals: editorial practices and author disclosures. Sci Eng Ethics. 2001;7:205-218. ISI | PUBMED
9. Ancker J, Flanagin A. A comparison of conflict of interest policies at peer-reviewed journals in multiple scientific disciplines. Paper presented at: The Fifth International Congress on Peer Review and Biomedical Publication; September 17, 2005; Chicago, Ill. http://www.ama-assn.org/public/peer/program.html. Accessed June 13, 2006.
10. Incorrect statements on funding/support and role of the sponsors and incorrect and incomplete financial disclosures [published correction online May 16, 2006]. JAMA. 2006;295:2482. http://jama.ama-assn.org/cgi/content/full/295/21/2482-c. Accessed June 13, 2006.
11. Ridker PM. Incomplete financial disclosure for study of funding and outcomes in major cardiovascular trials [letter]. JAMA. 2006;295:2725-2726. FREE FULL TEXT
12. Incomplete financial disclosure [correction]. JAMA. 2006;295:2726. FREE FULL TEXT
13. Cohen LS, Nonacs R, Viguera AC, et al. Antidepressant treatment and relapse of depression during pregnancy [letter]. JAMA. 2006;296:165-167. FREE FULL TEXT
14. Incomplete financial disclosure [correction]. JAMA. 2006;296:170. FREE FULL TEXT
15. Instructions for authors. JAMA. 2006;296:107-116.

RELATED ARTICLE
This Week in JAMA
JAMA. 2006;296:141.
FULL TEXT  




Talk is cheap. Use Yahoo! Messenger to make PC-to-Phone calls. Great rates starting at 1/min.

#1076 From: pulsecolo <pulsecolo@...>
Date: Sat Jul 22, 2006 5:16 pm
Subject: Medication Errors Injure 1.5 Million People and Cost Billions of Dollars Annually;
pulsecolo
Offline Offline
Send Email Send Email
 
 
Back | Home
News from the National Academies
Read Full Report

Date:  July 20, 2006
Contacts:  Christine Stencel, Media Relations Officer
Chris Dobbins, Media Relations Assistant
Office of News and Public Information
202-334-2138; e-mail <news@...>



FOR IMMEDIATE RELEASE

Medication Errors Injure 1.5 Million People and Cost Billions of Dollars Annually;
Report Offers Comprehensive Strategies for Reducing Drug-Related Mistakes

WASHINGTON -- Medication errors are among the most common medical errors, harming at least 1.5 million people every year, says a new report from the Institute of Medicine of the National Academies.  The extra medical costs of treating drug-related injuries occurring in hospitals alone conservatively amount to $3.5 billion a year, and this estimate does not take into account lost wages and  productivity or additional health care costs, the report says.

The committee that wrote the report recommended a series of actions for patients, health care organizations, government agencies, and pharmaceutical companies.  The recommendations include steps to increase communication and improve interactions between health care professionals and patients, as well as steps patients should take to protect themselves.  The report also recommends the creation of new, consumer-friendly information resources through which patients can obtain objective, easy-to-understand drug information.  In addition, it calls for all prescriptions to be written electronically by 2010 and suggests ways to improve the naming, labeling, and packaging of drugs to reduce confusion and prevent errors.

"The frequency of medication errors and preventable adverse drug events is cause for serious concern," said committee co-chair Linda R. Cronenwett, dean and professor, School of Nursing, University of North Carolina, Chapel Hill.  "We need a comprehensive approach to reducing these errors that involves not just health care organizations and federal agencies, but the industry and consumers as well," she said.  Co-chair J. Lyle Bootman, dean and professor, College of Pharmacy, University of Arizona, Tucson, added, "Our recommendations boil down to ensuring that consumers are fully informed about how to take medications safely and achieve the desired results, and that health care providers have the tools and data necessary to prescribe, dispense, and administer drugs as safely as possible and to monitor for problems.  The ultimate goal is to achieve the best care and outcomes for patients each time they take a medication."

Estimates of Rates and Costs

Medication errors encompass all mistakes involving prescription drugs, over-the-counter products, vitamins, minerals, or herbal supplements.  Errors are common at every stage, from prescription and administration of a drug to monitoring of the patient's response, the committee found.  It estimated that on average, there is at least one medication error per hospital patient per day, although error rates vary widely across facilities.  Not all errors lead to injury or death, but the number of preventable injuries that do occur -- the committee estimated at least 1.5 million each year -- is sobering, the report says.

Studies indicate that 400,000 preventable drug-related injuries occur each year in hospitals.  Another 800,000 occur in long-term care settings, and roughly 530,000 occur just among Medicare recipients in outpatient clinics.  The committee noted that these are likely underestimates.

There is insufficient data to determine accurately all the costs associated with medication errors.  The conservative estimate of 400,000 preventable drug-related injuries in hospitals will result in at least $3.5 billion in extra medical costs this year, the committee calculated.  A study of outpatient clinics found that medication-related injuries there resulted in roughly $887 million in extra medical costs in 2000 -- and the study looked only at injuries experienced by Medicare recipients, a subset of clinic visitors.  None of these figures take into account lost wages and productivity or other costs.

Improving the Patient-Provider Partnership

Establishing and maintaining strong partnerships between health care providers and patients is crucial to reducing medication errors, the report says.  The committee called on consumers to be active partners in their medication care and on physicians, nurses, and pharmacists to know and act on patients' medical care rights. 

The report recommends specific steps that physicians, nurses, pharmacists, and other health professionals should take to ensure that their patients are fully informed about their drug regimens and to minimize opportunities for mistakes to occur.  Health care organizations also should make it a standard procedure to inform patients about clinically significant medication errors made in their care, whether the mistakes lead to harm or not.  Currently, health care providers typically do not inform the patient or the patient's guardians about errors unless injury or death results.

The report also provides consumers with a list of specific questions to ask health care providers, such as how to take their medications properly and what to do if side effects occur.  Also included are actions consumers should take, such as requesting that their providers give them a printed record of the drugs they have been prescribed.  Patients should maintain an up-to-date list of all medications they use -- including over-the-counter products and dietary supplements -- and share it with all their health care providers.  This list should also note the reasons they are taking each product and any drug and food allergies they have. 

New and Improved Drug Information Resources

Although consumers can find helpful drug information online or in the printed materials provided by pharmacies, this information often is too difficult for many people to understand, too scattered, or otherwise not consumer-friendly.  The quality of the drug information leaflets that accompany prescriptions varies widely, and these printouts are typically written at a college reading level.  The U.S. Food and Drug Administration (FDA) should work with other appropriate groups to standardize the text and design of medication leaflets to ensure that they are comprehensible and useful to all consumers.

The committee called on the National Library of Medicine (NLM) to be the chief agency responsible for online health resources for consumers; it should create a Web site to serve as a centralized source of comprehensive, objective, and easy-to-understand information about drugs for consumers.  In addition, NLM should work with other groups to evaluate online health information and designate Web sites that provide reliable information.  The committee also recommended that NLM, FDA, and the Centers for Medicare and Medicaid Services evaluate ways to build and fund a national network of telephone helplines to assist people who may not be able to access or understand printed medication information because of illiteracy, language barriers, or other obstacles.  This telephone network should also enable consumers to report medication-related mistakes or problems.

Electronic Prescribing and Other IT Solutions

New computerized systems for prescribing drugs and other applications of information technology show promise for reducing the number of drug-related mistakes, the report says.  Studies indicate that paper-based prescribing is associated with high error rates.  Electronic prescribing is safer because it eliminates problems with handwriting legibility and, when combined with decision-support tools, automatically alerts prescribers to possible interactions, allergies, and other potential problems, the committee found.  While it acknowledged that significant regulatory issues and problems with automated alerts still need to be worked out, the committee said that by 2008 all health care providers should have plans in place to write prescriptions electronically.  By 2010 all providers should be using e-prescribing systems and all pharmacies should be able to receive prescriptions electronically.  The Agency for Healthcare Research and Quality (AHRQ) should take the lead in fostering improvements in IT systems used in ordering, administering, and monitoring drugs.

All health care provider groups should be actively monitoring their progress in improving medication safety, the committee recommended.  Monitoring efforts might include computer systems that detect medication-related problems and periodic audits of prescriptions filled in community pharmacies.

Drug Naming, Labeling, and Packaging

Confusion caused by similar drug names accounts for up to 25 percent of all errors reported to the Medication Error Reporting Program operated cooperatively by U.S. Pharmacopeia (USP) and the Institute for Safe Medication Practices (ISMP).  In addition, labeling and packaging issues were cited as the cause of 33 percent of errors, including 30 percent of fatalities, reported to the program.  Drug naming terms should be standardized as much as possible, and all companies should be required to use the standardized terms, the report urges.  FDA, AHRQ, and the pharmaceutical industry should collaborate with USP, ISMP, and other appropriate organizations to develop a plan to address the problems associated with drug naming, labeling, and packaging by the end of 2007.

The report also recommends studies to evaluate the impact of free drug samples on overall medication safety.  In general, there has been growing unease among health care providers and others about the way free samples are distributed and the resulting lack of documentation of medication use, as well as the bypassing of drug-interaction checks and counseling that are integral parts of the standard prescription process.

The study was sponsored by the U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services.  Established in 1970 under the charter of the National Academy of Sciences, the Institute of Medicine provides independent, objective, evidence-based advice to policymakers, health professionals, the private sector, and the public.  A committee roster follows.

                                                                                                                                                                   ;                                                   
Pre-publication copies of Preventing Medication Errors are available from the National Academies Press; tel. 202-334-3313 or 1-800-624-6242 or on the Internet at http://www.nap.edu.  Reporters may obtain a copy from the Office of News and Public Information (contacts listed above). 
#       #       #

[ This news release and report are available at http://national-academies.org ]

INSTITUTE OF MEDICINE
Board on Health Care Services

Committee on Identifying and Preventing Medication Errors

J. Lyle Bootman, Ph.D., Sc.D., (co-chair)
Dean and Professor
University of Arizona College of Pharmacy, and
Founding and Executive Director
University of Arizona Center for Health Outcomes and PharmacoEconomic Research
Tucson

Linda R. Cronenwett, R.N., Ph.D. (co-chair)
Professor and Dean
School of Nursing
University of North Carolina
Chapel Hill

David W. Bates, M.D., M.Sc.
Chief
Division of General Medicine
Brigham and Womens Hospital;
Medical Director of Clinical and Quality Analysis
Partners Healthcare System; and
Professor of Medicine
Harvard Medical School
Boston

Robert M. Califf, M.D.
Associate Vice Chancellor for Clinical Research;
Director
Duke Clinical Research Institute; and
Professor of Medicine
Division of Cardiology
Duke University Medical Center
Durham, N.C.

H. Eric Cannon, Pharm.D.
Director of Pharmacy Services and Health and Wellness
IHC Health Plans
Intermountain Health Care
Salt Lake City

Rebecca W. Chater, M.P.H.
Director of Clinical Services
Kerr Drug Inc.
Asheville, N.C.

Michael R. Cohen, Sc.D.
President
Institute for Safe Medication Practices
Huntington Valley, Pa.

James B. Conway, M.S.
Senior Fellow
Institute for Healthcare Improvement, and
Senior Consultant
Dana-Farber Cancer Institute
Boston

R. Scott Evans, Ph.D.
Senior Medical Informaticist
Department of Medical Informatics
LDS Hospital and Intermountain Health Care, and
Professor
Department of Medical Informatics
University of Utah
Salt Lake City

Elizabeth A. Flynn, Ph.D., R.Ph.
Associate Research Professor
Department of Pharmacy Care Systems
Harrison School of Pharmacy
Auburn University
Auburn, Ala.

Jerry H. Gurwitz, M.D.
Chief
Division of Geriatric Medicine;
Dr. John Meyers Professor of Primary Care Medicine; and
Executive Director
Meyers Primary Care Institute
University of Massachusetts Medical School
Worcester

Charles B. Inlander
President
Peoples Medical Society
Allentown, Pa.

Kevin B. Johnson, M.D., M.S.
Associate Professor and Vice Chair
Department of Biomedical Informatics, and
Associate Professor
Department of Pediatrics
Vanderbilt University Medical School
Nashville, Tenn.

Wilson D. Pace, M.D.
Professor of Family Medicine and Green-Edelman Chair for Practice-based Research
University of Colorado, and
Director
National Research Network
American Academy of Family Physicians
Aurora, Colo.

Kathleen R. Stevens, Ed.D., R.N.
Professor and Director
Academic Center for Evidence-Based Practice
University of Texas Health Science Center
San Antonio

Edward Westrick, M.D., Ph.D.
Vice President of Medical Management
University of Massachusetts Memorial Health Care
Worcester

Albert W. Wu, M.D.
Professor of Health Policy and Management and Internal Medicine
Johns Hopkins University
Baltimore

INSTITUTE STAFF

Philip Aspden, Ph.D.
Study Director


Why keep checking for Mail? The all-new Yahoo! Mail Beta shows you when there are new messages.

#1075 From: pulsecolo <pulsecolo@...>
Date: Wed Jul 19, 2006 2:38 am
Subject: advocates and media coverage....
pulsecolo
Offline Offline
Send Email Send Email
 
  Catherine Reuter-Lake  will be on Good Morning America tomorrow, July 19, to talk about the loss of her mother.  
 
Catherine Reuter-Lake is
Founder of
www.surgicalfire.org and a member of PULSE.
 
If anyone missed Montel today, http://www.montelshow.com/show/?showID=today the four advocates were very effective and much will be learned from them by the public.  Please send all who have been able to get media access your best wishes and support.    
 
Jennifer Dingman


Do you Yahoo!?
Next-gen email? Have it all with the all-new Yahoo! Mail Beta.

#1074 From: ICorina@...
Date: Fri Jun 9, 2006 9:21 am
Subject: Patient Advocate Survey-Please Help Circulate
icorinapc
Offline Offline
Send Email Send Email
 
If you have been hospitalized in the last 2 years, we want to know about your experience.
 
The Patient Advocate Survey; For those who have been hospitalized or cared for someone hospitalized in the last 2 years (2004-2006)
 
In this survey, we want to know what were some of the experiences that may have caused obstacles to receiving the best care and what may have worked to form partnerships with your healthcare provider. 
 
 
The information you provide anonymously will be used to design training and support materials for health care consumers and medical providers.  The information given is completely confidential and is not used by Survey Monkey nor will it be used by PULSE for any other reason than to gather the information on the survey. 
 
This survey should take no more than 10 minutes.
 
Thank you - and please feel free to distribute this to your list.
 
 
 
Ilene Corina
PO Box 353
Wantagh, NY 11793-0353
P(516)579-4711
F(516)520-8105
Cell (516) 650-2421
www.pulseamerica.org

GIVING THE PATIENT AND FAMILY A VOICE!


PULSE is a nonprofit 501 (c)(3) grassroots organization dedicated to raising awareness about patient safety and reducing medical errors through advocacy, education, and support. We work to empower the public to make informed decisions, increase effective communication and respect between healthcare providers and the public, and create community partnerships that will foster and ultimately lead to safer healthcare environments

#1073 From: pulsecolo <pulsecolo@...>
Date: Mon Jun 5, 2006 5:39 pm
Subject: Please Post Plastic Disasters
pulsecolo
Offline Offline
Send Email Send Email
 


Mary Anne Wyatt <mawyatt@...> wrote:
From: "Mary Anne Wyatt" <mawyatt@...>
To: "Jeni Dingman" <pulsecolo@... >
Subject: Please Post Plastic Disasters
Date: Mon, 5 Jun 2006 06:28:05 -0400

Jeni, please post this to the list.  I do not know how to do it.  Thanks, Mary Anne
 
 


Do you Yahoo!?
Everyone is raving about the all-new Yahoo! Mail Beta.

#1072 From: pulsecolo <pulsecolo@...>
Date: Fri Jun 2, 2006 12:28 am
Subject: Report examines patient satisfaction
pulsecolo
Offline Offline
Send Email Send Email
 
5. Report examines patient satisfaction
A new report -- http://www.pressganey.com/products_services/readings_findings/findings/ -- from Press Ganey summarizes survey findings from hospitals and other health care organizations that partner with the company to measure patient satisfaction. The inpatient section includes data from about 2.2 million patients treated at 1,576 hospitals during 2005.


Sneak preview the all-new Yahoo.com. It's not radically different. Just radically better.

#1071 From: pulsecolo <pulsecolo@...>
Date: Wed May 31, 2006 10:08 pm
Subject: no marketing please
pulsecolo
Offline Offline
Send Email Send Email
 
We cannot use our group to market anything as it might appear to be some sort of endorsement of a product or company..  sorry...


New Yahoo! Messenger with Voice. Call regular phones from your PC and save big.

#1070 From: "joseph_1280" <joseph_1280@...>
Date: Wed May 31, 2006 5:09 am
Subject: Online pharmacy
joseph_1280
Offline Offline
Send Email Send Email
 
Tired of waiting for your medication???
We offer speed delivery with in 3 days to any part of the world !!!
Online pharmacy that gives the best price on the web !!!.
You will be amazed to see the list of products that we offer.

http://thehttp218.com

No prescriptions needed
Online payment
Fast Delivery
Online Order Status

http://thehttp218.com
Confirm your order today and get exiting offers !!!

#1069 From: pulsecolo <pulsecolo@...>
Date: Tue May 30, 2006 10:50 pm
Subject: Doctor says hospital should have saved his wife
pulsecolo
Offline Offline
Send Email Send Email
 
 
 
Doctor says hospital should have saved his wife
M. ALEXANDER OTTO; The News Tribune
Patty Phillips didnt have to die, says her husband, Dr. Terry Phillips.
Had she received the emergency surgery she needed, he contends, she would have been home in Gig Harbor with him and their two sons in no time, and soon back to doing volunteer work with the homeless.
Instead, according to the lawsuit Phillips filed recently against the Franciscan Health System, owner of Tacomas St. Joseph Medical Center, his wifes condition was mishandled, leading to her death March 20.
This is the most devastating shock I have ever had in my life, Phillips said last week. The 56-year-old anesthesiologist has worked at St. Joseph for more than 11 years and still works at a Franciscan facility in Federal Way.
Franciscan declined to comment on the suit.
Its our policy not to comment on proposed or actual litigation, spokesman Gale Robinette said. Life was lost, and for that we express our deepest sympathies to the patients family and friends. We always strive to provide the best care to everyone who comes to us.
Patty Phillips went to the St. Joseph emergency room March 19 with excruciating abdominal pain. Because Dr. Phillips had seen such conditions before, he said he was certain his wife was experiencing a bowel infarction, which means a section of the small intestine had died and needed to be removed.
That called for an emergency operation, Phillips contends.
Bowel infarctions should be jumped on like a heart attack, he said.
Phillips said his wife should have had an imaging study that would have confirmed the bowel problem and led to immediate surgery. Also, he alleges in his suit, her doctor should have been told about the catatonic states shed slipped into twice March 19 because they were warning signs she was becoming sicker.
Most important, Phillips says in the suit, he repeatedly asked hospital staff to give his wife potassium because she was at grave risk for cardiac arrest. None of that happened, he says.
WHAT RECORDS SHOW
According to Phillips, his wife spent hours in a bed without standard monitoring machines in a storage area outside St. Josephs radiology unit.
By 7 p.m. March 19, according to her chart, she was clammy to (the) touch and her temperature was dropping. She was looking at (the) ceiling, eyes fixed, not responding and her respiration was shallow.
Her heart stopped shortly thereafter.
She was 55, a marathon runner and a triathlete.
A review of doctors and nurses notes for March 19 show Patty Phillips scheduled bowel study had been postponed until the next day. The record also shows Dr. Raheela Sadiq, the doctor overseeing her care, was told about the postponement. But theres no clear indication she was told about the first catatonic state at 4 p.m.
Sadiq ordered potassium be added to Phillips intravenous fluid, but the record doesnt show it was given. The record also shows 25 minutes elapsed before Sadiq was informed Phillips heart had stopped, though resuscitation efforts started before then.
The lawsuit blames hospital staff members for the death, alleging negligence.
John Christensen, the lawyer representing Terry Phillips and his two sons, 18 and 21, said the hospital is trying to pin the blame on Sadiq, alleging she did not take action regarding the first catatonic state.
Sadiqs lawyer, Steve Fitzer, said she was never told about it. Sadiq did not respond to an interview request by The News Tribune.
Christensen said that if an employee is found at fault in the death, Franciscan will be held liable for damages. The suit doesnt mention a dollar amount, but similar cases have resulted in millions of dollars changing hands.
If blame is pinned on someone who wasnt an employee, such as Sadiq, then Franciscan would be less liable, Christensen said.
He sees cOMBINATION OF ERRORS
Phillips said he doesnt doubt St. Joseph strives to do a good job. He counts many doctors there as friends and among the best in the business.
I dont have it in for St. Joes, he said. I really like the place; Ive always taken my family there.
He sees what happened to his wife as a combination of the kind of small errors that happen in medicine all the time, but that usually are isolated events that dont cause many problems.
Occasionally, all the bad things come together, Phillips said.
He is angry, though, that the potassium he is sure would have prevented his wifes heart from stopping was not given. Hes angry, too, that he wasnt kept informed about what was going on and for other lapses he alleges.
Perhaps his deepest anger is at how he says St. Joseph handled the aftermath of his wifes death.
Her brain had been destroyed by lack of oxygen due to the cardiac arrest. Doctors eventually restarted her heart, but by then it was too late. On March 20, Phillips had his wife removed from life support.
The autopsy found 20 inches of dead bowel.
Not soon after, he said, he got a call from St. Joseph saying everything that could have been done for his wife had been. The hospitals own chart review had proved it, he was told.
Right off the bat, that was a red flag, he said. Ive done a lot of chart reviews. (They) take weeks.
He started investigating.
If I had been a layperson, there is no way in the world I would have known what had happened to her, he said. Their explanation sounded so good.
A LITTLE DIFFERENT ATTITUDE
Phillips thought something wasnt right when he left his wife at St. Joseph. But he hadnt slept for several days and knew he needed rest.
He said he gave staff members the benefit of the doubt when they told him, Youre worrying too much. Shell be OK. We are taking good care of her.
And, Phillips said, things were too crazy in the ER that day to throw a hissy fit to make sure his wife got proper care.
Boy, am I sad I did not do that, he said.
Phillips said he sued because sometimes the only way to get the attention needed to improve things is to hit hospitals in the pocketbook.
I have a little different attitude about malpractice than most doctors, he said.
M. Alexander Otto: 253-597-8616
 
 


Do you Yahoo!?
Next-gen email? Have it all with the all-new Yahoo! Mail Beta.

#1068 From: pulsecolo <pulsecolo@...>
Date: Tue May 30, 2006 7:27 am
Subject: Lakewood doctor regains license
pulsecolo
Offline Offline
Send Email Send Email
 
Lakewood doctor regains license

His receptionist still faces charges

Posted by the Asbury Park Press on 05/29/06
BY KATHLEEN HOPKINS
TOMS RIVER BUREAU
TOMS RIVER A Lakewood abortion doctor who was accused last year of flushing fetuses into the sanitary sewer, a violation of the state's Clean Water Enforcement Act, is again practicing medicine after relinquishing his medical license for about eight months and completing a court intervention program.
The state Board of Medical Examiners in October reinstated the license of Dr. Flavius Thompson. However, he can only practice medicine at Kimball Medical Center in Lakewood under the supervision of another physician.
But Thompson's onetime receptionist, Liza Berdiel, still faces criminal charges that she performed nonsurgical abortions in his office on East County Line Road, Lakewood, without a license.
The office operated under the name Pleasant Women's Pavilion, a licensed abortion clinic.
Berdiel, 26, of Naomi Way, Jackson, was charged in an indictment last year with two counts of practicing medicine without a license, two counts of theft by deception that she accepted payment from patients for procedures she was not licensed to perform and uttering a forged instrument, writing a prescription for one of the patients.
Assistant Ocean County Prosecutor Martin J. Anton said Berdiel has applied to the court's pretrial intervention program, which offers defendants an opportunity to avoid a criminal record.
No decision has been made yet on whether Berdiel will be accepted into the program.
In the program, defendants do not admit guilt and are supervised for a period of time. If they do not get into trouble during that time and comply with the program's requirements, the charges against them are dismissed.
After her arrest Berdiel posted a bond and was released on her own recognizance, authorities have said.
Thompson, too, had faced criminal charges that he violated the state's Clean Water Enforcement Act by flushing fetuses into the sewerage system, said Assistant Prosecutor Hillary H. Bryce. He was accepted into the pretrial intervention program, which he successfully completed on May 22, Anton said.
Meanwhile, Thompson voluntarily surrendered his license to practice medicine in February 2005, according to a consent order he entered into with the state Board of Medical Examiners.
After Thompson resolved the criminal charge by entering the intervention program, the board in October lifted the remainder of a two-year period of suspension of his license and agreed to allow him to practice medicine, although restricted to a hospital setting and under the supervision of a board-approved monitor, according to the order.
Dr. Eric G. Lehnes, chairman of the Department of Obstetrics and Gynecology at Kimball Medical Center, was appointed Thompson's monitor, it said.
The board also ordered Thompson to successfully complete a course in ethics and infectious disease control within 12 months, and to pay investigative costs of $5,028.49, $17,373.50 in attorney's fees, and a civil penalty of $20,000. He is required to pay the total of $42,401.99 over two years in monthly installments.
The consent order said if Thompson wants the restrictions lifted from his license, he will have to convince the board that he has taken steps to ensure the safety of his practice, including arrangements for the proper disposal of medical waste.
"Only if the board is fully satisfied that (Thompson) may safely practice medicine and surgery pursuant to (his) plan for the resumption of private practice will he be relieved of the license restrictions," the consent order with the board of medical examiners said.


Blab-away for as little as 1/min. Make PC-to-Phone Calls using Yahoo! Messenger with Voice.

#1067 From: pulsecolo <pulsecolo@...>
Date: Tue May 30, 2006 7:28 am
Subject: Lakewood doctor regains license
pulsecolo
Offline Offline
Send Email Send Email
 
Lakewood doctor regains license

His receptionist still faces charges

Posted by the Asbury Park Press on 05/29/06
BY KATHLEEN HOPKINS
TOMS RIVER BUREAU
TOMS RIVER A Lakewood abortion doctor who was accused last year of flushing fetuses into the sanitary sewer, a violation of the state's Clean Water Enforcement Act, is again practicing medicine after relinquishing his medical license for about eight months and completing a court intervention program.
The state Board of Medical Examiners in October reinstated the license of Dr. Flavius Thompson. However, he can only practice medicine at Kimball Medical Center in Lakewood under the supervision of another physician.
But Thompson's onetime receptionist, Liza Berdiel, still faces criminal charges that she performed nonsurgical abortions in his office on East County Line Road, Lakewood, without a license.
The office operated under the name Pleasant Women's Pavilion, a licensed abortion clinic.
Berdiel, 26, of Naomi Way, Jackson, was charged in an indictment last year with two counts of practicing medicine without a license, two counts of theft by deception that she accepted payment from patients for procedures she was not licensed to perform and uttering a forged instrument, writing a prescription for one of the patients.
Assistant Ocean County Prosecutor Martin J. Anton said Berdiel has applied to the court's pretrial intervention program, which offers defendants an opportunity to avoid a criminal record.
No decision has been made yet on whether Berdiel will be accepted into the program.
In the program, defendants do not admit guilt and are supervised for a period of time. If they do not get into trouble during that time and comply with the program's requirements, the charges against them are dismissed.
After her arrest Berdiel posted a bond and was released on her own recognizance, authorities have said.
Thompson, too, had faced criminal charges that he violated the state's Clean Water Enforcement Act by flushing fetuses into the sewerage system, said Assistant Prosecutor Hillary H. Bryce. He was accepted into the pretrial intervention program, which he successfully completed on May 22, Anton said.
Meanwhile, Thompson voluntarily surrendered his license to practice medicine in February 2005, according to a consent order he entered into with the state Board of Medical Examiners.
After Thompson resolved the criminal charge by entering the intervention program, the board in October lifted the remainder of a two-year period of suspension of his license and agreed to allow him to practice medicine, although restricted to a hospital setting and under the supervision of a board-approved monitor, according to the order.
Dr. Eric G. Lehnes, chairman of the Department of Obstetrics and Gynecology at Kimball Medical Center, was appointed Thompson's monitor, it said.
The board also ordered Thompson to successfully complete a course in ethics and infectious disease control within 12 months, and to pay investigative costs of $5,028.49, $17,373.50 in attorney's fees, and a civil penalty of $20,000. He is required to pay the total of $42,401.99 over two years in monthly installments.
The consent order said if Thompson wants the restrictions lifted from his license, he will have to convince the board that he has taken steps to ensure the safety of his practice, including arrangements for the proper disposal of medical waste.
"Only if the board is fully satisfied that (Thompson) may safely practice medicine and surgery pursuant to (his) plan for the resumption of private practice will he be relieved of the license restrictions," the consent order with the board of medical examiners said.


Talk is cheap. Use Yahoo! Messenger to make PC-to-Phone calls. Great rates starting at 1¢/min.

#1065 From: pulsecolo <pulsecolo@...>
Date: Mon May 29, 2006 9:57 pm
Subject: Hawaii hospital beset by malpractice claims
pulsecolo
Offline Offline
Send Email Send Email
 
 
February 08, 2006

Hawaii hospital beset by malpractice claims

By Rob Perez
The Honolulu Advertiser
Tina Long, 26 and pregnant, was admitted to Tripler Army Medical Center in April, complaining of headaches, vision problems and swelling. Her blood pressure was elevated and she had protein in her urine. All were symptoms of a potentially serious disorder called preeclampsia.
The hospital ran tests on Long, who was 8½ months along, then placed her in a room without monitoring her closely, her family says.
About 90 minutes after someone from the nursing station last spoke to Long via a speaker system, she was discovered unresponsive in her bed. Resuscitation efforts failed, and Long and her unborn baby, Hunter, were pronounced dead, according to the autopsy report.
Two months later, a newborn boy, Romi’re Dupuy, experienced respiratory problems at Tripler, prompting medical personnel to place a breathing tube down his throat. But instead of maneuvering the tube through the trachea, a doctor mistakenly guided it into the esophagus, which leads to the stomach, puncturing that passageway and causing serious injury, the family said. Romi’re spent more than two months in the hospital recovering.
Both cases happened several months after a Tripler physician in January 2005 mistakenly gave a newborn baby, Izzy Peterson, carbon dioxide instead of oxygen almost immediately after his birth. The baby inhaled the wrong gas for more than 40 minutes before the error was discovered. He nearly suffocated and suffered permanent brain damage.
In all three cases, the families are pursuing medical malpractice claims or lawsuits, seeking compensation for what they allege was substandard care at Tripler.
The cases have generated questions about the overall quality of care provided at the landmark pink O’ahu hospital that serves as the major treatment facility for thousands of Hawai’i’s military, their families, veterans and others. It is ranked among the busiest hospitals in the military, with a coverage area that spans half the globe.
Four physicians contacted by The Advertiser who have expertise in treating children or in surgical procedures said the three cases were unusual. But while the doctors were reluctant to make judgments about the two more recent incidents, not knowing the complete details, they said the Baby Izzy case was particularly troublesome.
“It seems the system is broken that would allow such a severe mistake to happen,” said Dr. Timothy Craig, a Penn State professor of medicine and pediatrics who has practiced at military hospitals and generally gives them good marks. “This raises red flags.”
Tripler officials say that the hospital provides high-quality care and that outside inspectors regularly laud its services.
“When external surveyors and inspectors brief hospital leaders about their findings, most comment about our practices being the best they have ever seen — anywhere,” Tripler officials said in a statement.
Comparing the overall quality of care at Tripler with that provided at other hospitals, whether military or civilian, is difficult because of a lack of comprehensive, publicly available data.
The limited information available shows that Tripler compares favorably with other hospitals in Hawai’i but does not compare as well on a national basis.
Hawai’i hospitals as a group do not fare well in those national comparisons. In one recent survey, for example, local hospitals scored below the national averages in all 11 categories rated for treatment of heart-attack and heart-failure patients.
Tripler officials did not provide requested information for some important healthcare quality measures, including patient satisfaction surveys, lists of certifications and accreditations, and internal and external evaluations that the officials said verify Tripler is a first-class institution with an outstanding treatment history.
Prompted by the Baby Izzy case and others with troubling outcomes, The Advertiser examined available quality-of-care and medical malpractice data at the 229-bed military hospital.
Among the findings:
· The federal government has spent tens of millions of dollars over the past two decades to resolve about 170 cases among more than 600 filed in which patients or their families accused Tripler of shoddy care.
The tab to taxpayers has totaled more than $60 million in court judgments, out-of-court settlements and resolution of medical malpractice claims. The government, for instance, has paid more than $14 million to resolve about 150 claims since 1985. In one 1998 claim, a family received $130,000 for an incident in which a Tripler patient allegedly needed corrective surgery to remove a sponge left behind during an earlier operation.
Court judgments and out-of-court settlements have added about another $47 million to the tab. But that isn’t a complete accounting, given that out-of-court settlements sometimes are not disclosed publicly.
· Tripler and other federal entities have been unwilling or unable to quantify how much malpractice cases at Tripler have cost over the past decade, leaving taxpayers in the dark about a tab they ultimately covered.
· Since 1985, the government has lost 14 of 23 nonjury trials in which malpractice was a key issue. The government has lost five of its past six cases since 1995, including one it lost on appeal, according to Personal Injury Judgments Hawaii, a publication that tracks tort verdicts in state and federal courts here. In the 14 losses, a federal judge determined that substandard care contributed to a patient’s death or injury, and in all but one instance awarded damages of at least six figures to the plaintiffs. The largest judgment, $11.3 million in 1997, was awarded to a family whose baby suffered brain damage because of negligent care.
· While some of the more costly cases occurred in the 1980s and early ‘90s, allegations of poor care continue to dog Tripler. Patients or their families filed 331 medical malpractice claims from January 1995 through July 2005, according to Army data obtained by The Advertiser through the Freedom of Information Act. In the previous 10 years, 312 claims were filed.
In an October statement about Tripler’s overall operation, officials said the hospital provides safe, compassionate, high-quality care. They said the malpractice claims against the hospital follow national trends, with more filed for high-risk care performed commonly, such as complex maternal care and neonatal intensive care.
“We see nothing in our data that suggests our care is less safe than at other military medical centers or civilian hospitals providing comparable services,” the officials said in their written response to Advertiser questions.
In addition, they said Tripler remains accredited and certified “in every way” by outside organizations that evaluate its services.
Its main accreditation was renewed by the Joint Commission on Accreditation of Healthcare Organizations in December 2004, with the commission finding Tripler in full compliance with the reviewed standards. Accreditations come up for renewal every three years, though that scheduling will become more random beginning next year.
Tripler officials declined comment on cases in litigation: “We take each claim on its merit, investigate it and take appropriate action.”
In November, Tripler officials told The Advertiser they would no longer respond to requests for information, directing further inquiries to the hospital’s Mainland headquarters. Since then, that Texas office has not provided most of the information sought by the newspaper.
400,000 Eligible
The hospital gets an estimated 50,000 patient visits a month, while another 14,000-plus occur at Schofield Barracks Health Clinics, part of the Tripler system. More than 400,000 people are eligible to receive care at Tripler.
The hospital also serves as a teaching institution for more than 1,200 medical personnel each year, including students at the University of Hawaii medical school. That arrangement allows resident physicians or other trainees to work alongside their mentors, similar to what happens at other teaching hospitals in the state and elsewhere.
The vast majority of Tripler cases never generate malpractice complaints.
Many patients typically are satisfied with their care or, if something bad happens, are satisfied with the explanation.
Shigeo Doc Kawamoto, a veteran of World War II, counts himself among the people pleased with Tripler’s services. He periodically gets medical tests done at the hospital.
“They take good care of me,” Kawamoto said. “They treat me well.”
Some patients are reluctant to pursue claims, while active-duty members are prohibited from doing so. Military personnel — about a third of Tripler’s patient pool — are barred by law from filing malpractice claims against the U.S. government for injuries linked to their military service, even if an injury stems from gross negligence by a government worker.
For those patients or families who formally seek compensation, the first step is to file a malpractice claim with the government. If that isn’t resolved within six months, a lawsuit can be filed in federal court. A judge, not a jury, renders a verdict.
Among the Army’s seven medical centers in the U.S., Tripler’s 331 claims and 61 paid claims over the past decade were second only to the totals at William Beaumont Army Medical Center at Fort Bliss, Texas, that has 94 licensed beds. The Army didn’t respond to requests asking about Beaumont’s numbers.
Tripler officials said the hospital’s malpractice claim statistics can’t be compared with Army medical centers elsewhere because of differences in state laws, malpractice tort reform, the aggressiveness of malpractice attorneys and other local factors unrelated to quality of care.
Three local malpractice attorneys dispute that, saying a legitimate claim will be valid anywhere, regardless of the idiosyncrasies of a particular area.
Tripler officials also said, “We cannot comment on whether people in Hawaii file more claims than in other places.”
No organization compiles state-by-state comparisons of filed malpractice claims, according to those who track other malpractice data.
Rules for Openness
Industry executives and attorneys say medicine can be an inexact science, and mistakes happen at every hospital.
Mistakes at Tripler, however, have a greater chance of becoming public because of open-government regulations, particularly if lawsuits result. Mistakes at private institutions, especially the more egregious errors, tend to be dealt with secretly at the insistence of the hospitals and doctors, half-a-dozen plaintiff attorneys said.
“Our really slam-dunk (civilian) cases settle with confidentiality,” said plaintiff attorney Rick Fried.
Even lawyers who have filed malpractice lawsuits involving Tripler say the hospital provides better care today than years ago.
“By and large, I think Tripler is a terrific public health institution,” said attorney Eric Seitz, who represented a client in a recently settled lawsuit alleging substandard care at Tripler. “There are some wonderful doctors there.”
Yet developments over the past year have once again raised questions about quality of care.
In the Baby Izzy case, a portable carbon dioxide tank was used instead of an oxygen tank, resulting in a “sentinel event,” according to a federal patient safety alert on the mishap. Sentinel events typically refer to medical incidents that unexpectedly result in death or serious injury.
After the gas mix-up, the hospital apologized to the family and said immediate corrective action was taken.
“Providing carbon dioxide instead of oxygen is inexcusable,” said Dr. Peter Lurie, deputy director of health research for Public Citizen, an advocacy group that focuses on healthcare and other consumer issues.
The incident prompted the Department of Defense in March to issue the military-wide alert advising medical institutions to take immediate steps to prevent similar mishaps.
Izzy’s brain damage was so severe, he is dependent on medical devices for his survival. He will need 24-hour nursing care the rest of his life.
Shalay Peterson, Izzy’s mother, said Izzy will never be able to lead a normal life or do the typical things that kids do together with their families.
“We’ve been robbed of all that,” she said.
Izzy’s parents have sued the government for malpractice, and plaintiff attorneys say a judgment, if the case goes to trial and the family wins, could be one of the highest in Tripler history. The current record is the $11.3 million award in 1997 to the family of the brain-damaged baby. With interest, the government paid about $12.5 million.
The government denied in court documents that Tripler was negligent with Izzy’s care. The case is pending.
Long’s Symptoms
Tina Long was admitted last April with these symptoms: high protein levels in her urine, severe headaches, swelling, blurred vision and elevated blood pressure of 159/100 when it had been an average of 120/77 in prior months, according to Michael Archuleta, the family’s attorney in Texas. All those general symptoms were noted in the autopsy report.
For pregnant women, high blood pressure and protein in the urine are the key symptoms of preeclampsia, according to Eleni Tsigas of the Preeclampsia Foundation. Preeclampsia is a rapidly progressing hypertensive condition that affects pregnant women and can be harmful to the unborn baby and mother. Severe headaches, swelling of the hands and face, and blurred vision are among other indicators.
Women who have high blood pressure during pregnancy typically are closely monitored because that condition may progress to preeclampsia, Tsigas said.
When Long was hospitalized in April, the diagnosis — made about 12 hours before she died — was to “rule out preeclampsia,” according to the autopsy report. A “rule-out” diagnosis usually means the disorder is suspected but not enough evidence is available at the time to make a definitive call, doctors say.
Archuleta said Long’s case was a textbook one for preeclampsia. Yet Tripler not only failed to monitor the patient adequately but didn’t do the one thing that would have taken care of the problem — deliver the baby, according to Archuleta, who also is a doctor and says he has delivered about 100 babies.
The cause of Long’s death was listed as probable peripartum cardiomyopathy (a weakened, damaged heart during pregnancy), with toxemia of pregnancy — another name for preeclampsia — noted as a contributing cause, according to her autopsy.
“There’s a difference between warehousing a patient and treating a patient,” Archuleta said. “Tina was warehoused.”
Long’s family filed several malpractice claims against Tripler, seeking $40 million in compensation. The claims are pending.
Tripler officials declined comment because it is an ongoing case.
The family of Romi’re Dupuy, the baby whose esophagus allegedly was punctured, also filed several claims, seeking $15 million. Tripler likewise declined comment.
Death in Childbirth
Another pending case that surfaced last year involved a Marine now stationed on the Mainland who in May sued the federal government on behalf of his late wife’s estate, alleging that Tripler’s negligent care led to her death and their newborn son’s brain injury. Vincent Adams said in the lawsuit that an improperly administered epidural — a type of anesthesia procedure used for childbirth — led to complications in December 2002 during delivery and afterward that injured their son and caused the death of Jennifer Adams four months later in Florida.
Vincent Adams said in a March 2003 videotaped interview that a Tripler doctor told him a high epidural caused his wife to stop breathing.
William Copulos, Adams’ attorney, said a high epidural or high spinal epidural refers to one that is administered in such a way that the anesthetic travels upward in the body. In Jennifer Adams’ case, the epidural needle was inserted in her cerebral spinal fluid space instead of the epidural space, allowing the anesthetic to travel up the spinal column, anesthetizing her heart and diaphragm, Copulos said.
A Florida medical examiner determined in May 2003 that Jennifer Adams’ death was due to complications from a high spinal epidural, according to the examiner’s report. The Adams lawsuit is pending. The government denied in court documents that the care was negligent.
The issue of quality of care also came up in an August court ruling by U.S. District Judge Susan Oki Mollway. A woman patient who was sexually molested by a male licensed practical nurse at Tripler in 2001 subsequently sued the government, accusing Tripler of negligence.
Mollway awarded the woman and her husband $906,000, finding that Tripler’s inattention to the patient and inadequate supervision of the male nurse who treated her were substantial factors in the sexual assault. The nurse pleaded guilty to sexual abuse and was sentenced in 2002 to 6 1/2 years in prison.
A first-year intern and a supervisory nurse who oversaw the care of the woman at the intensive-care unit paid little attention to the patient that night, even though the woman kept losing and regaining consciousness and a diagnosis was unclear, according to Mollway’s ruling.
The government is appealing the ruling. The U.S. attorney’s office, which is handling the appeal, declined comment.
Quality Assurance
In a June interview, Navy Capt. Kevin Berry, deputy commander for clinical services at Tripler, said the hospital regularly keeps on top of quality issues and patient safety. The hospital, for instance, has a full-time safety manager whose focus is to identify issues that have patient safety implications and to develop plans to reduce or eliminate the potential to cause harm. In addition, Tripler is inspected by one dozen to three dozen external organizations, Berry said.
“There are literally thousands of layers to a medical quality assurance program,” he said.
If something goes wrong and a peer-review process determines substandard care was given, those responsible are held accountable, he said.
But Tripler officials said the hospital rarely has incidents that require reporting physicians to state or national boards. They said they do not keep statistics on such reports.
Plaintiff attorney Mark Davis, who noted that his law firm over the years has won all 15 or so of its Tripler malpractice cases that went to trial, said common issues tended to surface: understaffing, poor continuity of care, lapses in record-keeping, inadequate supervision of personnel.
Tripler said it maintains staffing standards similar to or more stringent than those used by some civilian hospitals, reviews staff levels frequently and makes adjustments as needed, including periodically referring patients to other hospitals here or on the Mainland.
Most other issues raised by malpractice attorneys are conjecture, Tripler said.
Yet some of those very issues have surfaced in recent cases.
In the sexual assault case, Judge Mollway noted that the supervisory nurse had asked for more help that night, expressing concern that the intensive-care unit where the eventual assault occurred was understaffed. The nurse received no response to her request, according to the ruling.
In the Tina Long case, the patient never saw the same doctor regularly, contributing to her inconsistent or poor care, the family said. During her hospitalization in April, a physician asked Long’s mother to retrieve medication for her daughter from a downstairs pharmacy because no hospital staffer was available to get it, the family said.
In the Baby Izzy case, Shalay Peterson said that when she asked for Izzy’s records in preparation for a move to the Mainland, she was given a file that included documents from a different case, one of a boy who died at Tripler.
In the Adams case, the epidural was administered by a nurse anesthetist, but once the patient started having problems, the anesthesiologist should have been summoned to intervene, according to Copulos, the family’s attorney. That didn’t happen, he said.
 


New Yahoo! Messenger with Voice. Call regular phones from your PC and save big.

#1064 From: pulsecolo <pulsecolo@...>
Date: Mon May 29, 2006 8:01 pm
Subject: Fwd: articles needed
pulsecolo
Offline Offline
Send Email Send Email
 


ICorina@... wrote:
From: ICorina@...
Date: Mon, 29 May 2006 07:40:45 EDT
Subject: articles needed
To: HHask@..., pulsecolo@..., rgibson@...

Have you heard the term " No one in healthcare wakes up in the morning wanting to hurt someone"?  I have heard it once too often.  I have no idea if they do or not but I surely know that no one can speak for everyone.
 
I have started saving articles (and would love your help getting more) about medical people, nurses, doctors, dentists who have committed crimes or caused injury - sometimes not related to healthcare.
 
Medical folks always say that "no one in healthcare wants to hurt someone".  That is not a fair statement and that is one of the things I believe is causing us problems.
 
Some doctors and nurses are criminals and some are just not good at their work but keep working.  If we allow that kind of remark to continue "no one in healthcare gets up in the morning wanted to injure someone" we have opened the doors to allow medical people who are injuring and killing to continue.
 
I would never say "no patient wakes up in the morning wanting to sue their doctor"  I have no idea if they do or not.  I know what I have dealt with and what I have seen - no more, no less.
 
But, I continue to read about medical people who have committed crimes, acted inappropriately causing pain to someone and sometimes unrelated to healthcare have caused harm (drunk driving, sexual relations, stealing body parts)  and have a collection piling up.  Please keep your eyes open for these kinds of articles
 
thanks.
 
ilene


Do you Yahoo!?
Everyone is raving about the all-new Yahoo! Mail Beta.

#1063 From: pulsecolo <pulsecolo@...>
Date: Sat May 27, 2006 3:38 pm
Subject: PULSE Survey
pulsecolo
Offline Offline
Send Email Send Email
 


You do not need to live in NY to do this survey, your help is greatly appreciated.
 
PULSE of NY, Inc. is presently conducting a brief survey for people who have been hospitalized in the past 2 years.  If you have been hospitalized between the years 2004 and 2006 please go to the link below and complete this survey.  If you know of someone else who has been hospitalized, please feel free to ask them to complete this survey.  Survey's will be kept completely confidential. 
 
Individual surveys requesting more detail for New Yorkers are available by contacting me at icorina@... and can be received through the US Mail, by fax or on-line.
 
To complete a brief survey (10 questions) if you have been hospitalized recently, please vist:
 
 
Thanks for your participation,
 
 
Ilene Corina, President
PULSE of NY, Inc.
PO Box 353
Wantagh, NY 11793-0353
P(516)579-4711
F(516)520-8105
Cell (516) 650-2421


Talk is cheap. Use Yahoo! Messenger to make PC-to-Phone calls. Great rates starting at 1¢/min.

#1062 From: pulsecolo <pulsecolo@...>
Date: Sat May 27, 2006 3:17 pm
Subject: CDC urges infection testing for tissue recipients
pulsecolo
Offline Offline
Send Email Send Email
 
 
CDC urges infection testing for tissue recipients
Fri May 26, 8:29 AM ET
Inaccurate record keeping, ineligible donors, and failure to screen donor tissues for infectious diseases have led the U.S. Centers for Disease Control and Prevention to recommend recipients of tissue implants supplied by Biomedical Tissue Services, Ltd, (BTS) of Fort Lee, New Jersey, undergo testing for infectious diseases.
Dr. M. Malarkey, from the US Food and Drug Administration (FDA), and associates report that, late last year, an investigation of BTS by the FDA revealed that information regarding cause, place or time of death did not match information on the donors' death certificates. They also found sloppy recovery methods that failed to control contamination of the tissue.
As reported in the Morbidity and Mortality Weekly Report, approximately 25,000 BTS tissue products were sent to five tissue processors and then distributed to all 50 states and internationally between June and October.
In October, BTS and the five processors that received the tissues were ordered to issue a recall of all unused product.
The recall letters were sent to the doctors and healthcare facilities that had bought the products and included a recommendation by the FDA and CDC that tissue recipients be notified of the recall and offered to be tested for HIV, hepatitis B, hepatitis B and syphilis.
In January of this year, the US Food and Drug Administration ordered BTS to cease manufacturing and distributing all cells, tissue, and cellular and tissue-based products. Most of the products were bone, skin, and soft tissue such as tendons.
Then in March, the FDA found out that some of the blood samples submitted for disease screening were not from the alleged donors.
The CDC advises that the involved patients whose tissue implants had been in place for longer than 6 months be tested. Patients who received the tissue implant less than 6 months earlier could also be tested, but retesting will the needed after the 6-month mark.
Patients with test positive for an infectious disease should undergo further testing to confirm the diagnosis, the authors note, and positive test results should be reported to local or state health departments, the tissue distributor, FDA's MedWatch program (http://www.fda.gov/medwatch) or the CDC (phone number 800-893-0485).
Patients who do not know where the tissue implants came from should ask their doctors. If the doctors don't know the source of the tissue, they should contact the facility or distributor that provided the tissues, or call their state or local health department.
MNWR, May 26, 2006.
 


Yahoo! Messenger with Voice. PC-to-Phone calls for ridiculously low rates.

#1061 From: pulsecolo <pulsecolo@...>
Date: Sat May 27, 2006 7:28 am
Subject: Fwd: Readers Digest Reporter
pulsecolo
Offline Offline
Send Email Send Email
 


ICorina@... wrote:
From: ICorina@...
Date: Wed, 24 May 2006 13:55:01 EDT
Subject: Readers Digest Reporter
To: undisclosed-recipients:;


 
Please distribute appropriately.  The following was received after a phone conversation.  The contact information follows.
 
 
 
Reader's Digest magazine is working on a story about medical errors.  Our story focuses in part on errors that occur in pathology labs.  These errors include misidentification of lab specimens (attaching the wrong ID label to the specimen), misinterpretation of the specimen resulting in incorrect diagnosis, loss of the specimen, etc.  Our article examines the prevalence and impact of these types of errors, and suggests ways to help patients and medical professionals reduce the risk of such errors occurring.

In order to raise awareness about this problem, and convey the full human impact of these errors to our readers, we would like to include a real-life story of a patient who has been the victim of a lab error.  Specifically, we would like to present readers with a case in which a patient's lab specimen (such as a blood sample or tissue biopsy) was mixed up with that of another patient, leading to an incorrect diagnosis.  In other words, a case in which a patient was told he or she had a disease, such as cancer, based on another patient's tissue sample, as a result of a mix-up of the two patients' specimens in the lab.  We would also be interested in any cases involving a misinterpretation or faulty analysis of a specimen by the pathologist or lab technician, leading to misdiagnosis.

In order to effectively convey the impact of this problem to our readers, we would need to be able to use the error victim's full name in our article.  The error must have resulted in some harm to the victim--either physical or emotional.  The incident must have occurred within the last five or six years.  The incident must be fully verifiable, and the hospital or other healthcare professionals involved must have reached some legal settlement with the victim, or otherwise acknowledged liability for the error.

If you have undergone an experience similar to that described here, and would be willing to share your story for publication in Reader's Digest, please contact me by Thursday, May 25, at the following email address: joseph_vetter@...

Thank you for your help in raising awareness about this public health problem.

Sincerely,
Joe Vetter
Reporter
Reader's Digest
joseph_vetter@...



How low will we go? Check out Yahoo! Messengers low PC-to-Phone call rates.

#1060 From: pulsecolo <pulsecolo@...>
Date: Wed May 24, 2006 10:31 pm
Subject: Taking common painkillers ups elderly's heart failure risk
pulsecolo
Offline Offline
Send Email Send Email
 

Taking common painkillers ups elderly's heart failure risk
http://www.chinaview.cn/ 2006-05-23 08:59:52

    BEIJING, May 23 (Xinhuanet) -- Taking commonly-used painkillers called non-steroidal anti-inflammatory drugs (NSAIDs) could increase the risk of heart failure among the elderly by almost a third, according to a new study published in the online edition of the journal Heart Tuesday.
    For the study, the researchers from the Spanish Centre for Pharmacoepidemiologic Research in Madrid reviewed the data of 228,660 patients on Jan. 1, 1997 and followed them till the end of 2000.
    Of the patients admitted to the hospital, 14 percent were on NSAIDs painkillers at the time of their admission as compared to 10 percent of patients selected randomly. Over 50 percent of those admitted to the hospital belonged to the age group of 70 to 79 years.
    Indomethacin (indocin) was associated with the highest risk for heart failure. Patients who took it were three times as likely to be admitted to the hospital than those who did not. Osteoarthritis was the most common condition for which the NSAIDs painkillers were used.
    The researchers stressed that based on their survey there would be one extra first hospital admission for heart failure at the rate of one in every 1,000 people taking painkillers.
    They admitted that the risk is very small. But this figure could very well increase given the fact that most of the elderly aged 60 to 84 are likely to suffer from diabetes, high blood pressure, or kidney failure.
    "Even a small increase in the risk can translate into a significant disease burden in the general population," the researchers noted, adding heart failure is a common cause of illness and death among the elderly.
    They pointed out that their results are compatible with the findings of other published studies indicating that NSAIDs exacerbate heart failure symptoms, leading to hospitalization among susceptible patients, such as those with a history of cardiovascular disease and, in particular, previous heart failure.
    Meanwhile, June Davison, medical spokeswoman for the British Heart Foundation, said the study confirmed that the use of NSAIDs may increase symptoms in people who have heart failure.
    She said: "Many people who are prescribed this medication suffer debilitating pain from inflammatory diseases, such as rheumatoid arthritis. These people may consider the possible slight increase in risk of heart failure symptoms to be acceptable."  Enditem
(Agencies)
Editor: Lu Hui


How low will we go? Check out Yahoo! Messengers low PC-to-Phone call rates.

#1059 From: pulsecolo <pulsecolo@...>
Date: Wed May 24, 2006 10:29 pm
Subject: Pills Rendering Menstrual Period Optional
pulsecolo
Offline Offline
Send Email Send Email
 
 
May 21, 2006, 7:54PM
Pills Rendering Menstrual Period Optional
By LINDA A. JOHNSON Associated Press Writer
© 2006 The Associated Press
TRENTON, N.J. — For young women with a world of choices, even that monthly curse, the menstrual period, is optional.
Thanks to birth control pills and other hormonal contraceptives, a growing number of women are taking the path chosen by 22-year-old Stephanie Sardinha.
She hasn't had a period since she was 17.
"It's really one of the best things I've ever done," she says.
A college student and retail worker in Lisbon Falls, Maine, Sardinha uses Nuvaring, a vaginal contraceptive ring. After the hormones run out in three weeks, she replaces the ring right away instead of following instructions to leave the ring out for a week to allow bleeding. She says it has been great for her marriage, preventing monthly crankiness and improving her sex life.
"I would never go back," said Sardinha, who got the idea from her aunt, a nurse practitioner.
Using the pill or other contraceptives to block periods is becoming more popular, particularly among young women and those entering menopause, doctors say.
"I have a ton of young girls in college who are doing this," says Dr. Mindy Wiser-Estin, a gynecologist in Little Silver, N.J., who did it herself for years. "There's no reason you need a period."
Such medical jury-rigging soon will be unnecessary. Already, the Seasonale birth control pill limits periods to four a year. The first continuous-use birth control pill, Lybrel, likely will soon be on the U.S. market and drug companies are lining up other ways to limit or eliminate the period.
Most doctors say they don't think suppressing menstruation is riskier than regular long-term birth control use, and one survey found a majority have prescribed contraception to prevent periods. Women have been using the pill for nearly half a century without significant problems, but some doctors want more research on long-term use.
The new methods should be popular. A non-scientific Web survey for the Association of Reproductive Health Professionals found at least two-thirds of respondents are bothered by fatigue, heavy bleeding, "really bad cramps" and even anger. Nearly half said they would like to have no period at all or decide when to have one.
For some women, periods can cause debilitating pain and more serious problems.
Two recent national surveys found about 1 in 5 women have used oral contraceptives to stop or skip their period.
"If you're choosing contraception, then there's not a lot of point to having periods," says Dr. Leslie Miller, a University of Washington-Seattle researcher and associate professor of obstetrics and gynecology whose Web site, noperiod.com, explains the option. She points out women on hormonal contraception don't have real periods anyway, just withdrawal bleeding during the break from the hormone progestin.
According to Miller, modern women endure up to nine times more periods than their great-grandmothers, who began menstruating later, married young and naturally suppressed periods for years while they were pregnant or breast-feeding. Today's women may have about 450 periods.
Still, surveys also show most women consider monthly periods normal. Small wonder: Girls learn early on that menstruation is a sign of fertility and femininity, making its onset an eagerly awaited rite of passage.
The period is "way over-romanticized," says Linda Gordon, a New York University professor specializing in women's history and the history of sexuality.
"It doesn't take long for women to go from being excited about having a period to feeling it's a pain in the neck," said Gordon, author of "The Moral Property of Women: A History of Birth Control Politics in America."
She says caution is needed because there's not enough data on long-term consequences of using hormones continuously. Gordon notes menopausal women for years were told that hormone drugs would keep them young _ until research uncovered unexpected risks.
"People should proceed very cautiously," she says.
Today's birth control pills contain far less estrogen and progestin than those two generations ago, but still increase the risk of heart attack, stroke and blood clots. The pill should not be used by women who have had those conditions, unexplained vaginal bleeding or certain cancers, or if they are smokers over 35.
But there are benefits from taking oral contraceptives too, such as a lower risk of ovarian and endometrial cancer, osteoporosis and pelvic inflammatory disease. And forgoing periods means no premenstrual syndrome and a lower risk of anemia and migraines, says Dr. Sheldon Segal, co-author of "Is Menstruation Obsolete?" Segal has been involved in research for several contraceptives.
Almost since the first pill arrived in 1960, women have manipulated birth control to skip periods for events such as a wedding, vacation or sports competition. Female doctors and nurses were among the first to block menstruation long-term to suit their schedules, said Susan Wysocki, head of the National Association of Nurse Practitioners in Women's Health.
"They were then more comfortable recommending it to their patients," said Wysocki, who uses a vaginal ring to prevent menstruation.
The idea gained momentum after Barr Pharmaceuticals launched Seasonale in November 2003. It's a standard birth control pill taken for 12 weeks, with a break for withdrawal bleeding every three months. Amid wide acceptance by doctors, sales shot up 62 percent last year, to $110 million.
Publicity for Seasonale made women wonder, if just four periods a year are OK, why have any at all?
Users of Pfizer Inc.'s Depo-Provera, a progestin-only contraceptive shot lasting three months, usually are period-free after a year or two. There's now a generic version, but the drug can thin bones.
And many women have been getting extra prescriptions so they could continuously stay on birth control pills, the Ortho Evra patch or the vaginal ring, rather than bleeding every fourth week. That schedule was set by the original birth control designers to mimic normal menstrual cycles. But the extra prescriptions have led to insurance company hassles.
"What Seasonale did is get rid of that nuisance," says Dr. Peter McGovern of University of Medicine and Dentistry of New Jersey.
New extended-cycle contraceptives will do the same. Wyeth is hoping by late June to get Food and Drug Administration approval to sell Lybrel, its low-dose, continuous birth control pill; approval also is pending in Canada and Europe.
Also in June, FDA should decide whether to approve Implanon, a single-rod, three-year contraceptive implanted in the upper arm that maker Organon USA has been selling it in Europe for a decade.
Berlex Inc. is developing its own birth control pill for menstrual suppression.
Barr, aiming to be a leader in extended contraception, last November bought the maker of ParaGard, an intrauterine device that blocks periods in some women. Barr's new product Seasonique, a successor to Seasonale, likely will get federal approval at week's end.
Dr. Patricia Sulak, who researches extended contraception at Texas A&M College of Medicine, applauds this new trend. The doses in standard pills are now so low, she said, that having seven days off them raises the risk of pregnancy.
"This redesign is way overdue," she says. "It's going to be the demise of 21-7."
___
On the Net:
Dr. Leslie Miller's site: http://www.noperiod.com/
Association of Reproductive Health Professionals: http://www.arhp.org/


Be a chatter box. Enjoy free PC-to-PC calls with Yahoo! Messenger with Voice.

Messages 1059 - 1090 of 1119   Newest  |  < Newer  |  Older >  |  Oldest
Advanced
Add to My Yahoo!      XML What's This?

Copyright 2009 Yahoo! Inc. All rights reserved.
Privacy Policy - Terms of Service - Guidelines - Help